ࡱ> a _bjbj 4xJ\xJ\VN VVVVVjjj8~|jLF\\\& kmmmmmm$8nVVV\\4F!F!F!V\V\kF!kF!F!&ݙ\-FdW0!^ ݙݙfVCF!F! > :  Course Title: Ambulatory Care Advanced Pharmacy Practice Experience Course Purpose: The goal of the Ambulatory Care Advanced Pharmacy Practice Experience is to provide opportunities for students to build on knowledge and skills acquired through didactic education and introductory pharmacy practice experiences and apply them in direct patient care activities in the ambulatory care setting. This course takes place in an ambulatory care, multidisciplinary practice setting. Practice sites may include hospital-based clinics, physician group practices, community or public health clinics, managed care facilities that provide health care directly to patients, or similar practice settings. Students will actively participate in direct patient care, including obtaining patient medical and medication histories, evaluating drug therapies, developing pharmacy care plans, monitoring patients' therapeutic outcomes, consulting with physicians and non-physician providers, and providing education to patients and health care professionals. Preceptor(s) and Site Information: PRECEPTOR: insert the following information Site Name: Site Address: Preceptor Name(s): Preceptor Phone: Preceptor Email: Pharmacy Phone Number: Pharmacy Fax Number: Pre-Rotation Requirements for Student Students are responsible for completing requirements set forth by the University of Florida, College of Pharmacy. Check the PharmAcademic website for site-specific forms and requirements (i.e., Drug Screen Requirements, Immunization forms. Students must request attestations at least 60 days BEFORE the scheduled rotation is to begin. PRECEPTOR: Include any information or documentation that the student must provide (i.e. immunization requirements, HIPAA training, etc.) prior to starting rotation. Note that prerequisite knowledge and skills (recommended review of therapeutic guidelines, etc.) are specified in a subsequent section. Learning Objectives: At the conclusion of the Ambulatory Care Advanced Pharmacy Practice Experience, students should be able to: Conduct a patient/caregiver interview to gather information about the patient's medication therapy and health status with consideration about the patient's culture, level of education, socioeconomic status, and emotional state of mind. Formulate a concise and evidence-based patient-centered care plan in collaboration with other health care professionals, patients, and/or their caregivers which considers the patient's health literacy, culture, and psychosocial factors. Communicate with another health care professional about the appropriateness of a patient's pharmacotherapy with clarity and accuracy (drug, dosing, dosage forms, routes of administration, delivery systems). Communicate with patients, families, communities, and other health professionals in a responsive and responsible manner that supports a team approach to the maintenance of health and the treatment of disease. Prepare an accurate, concise, and organized written patient care plan. Implement, monitor, evaluate, and adjust pharmaceutical care plans with accuracy and timeliness. Provide patient education/counseling to a diverse population of patients/caregivers which effectively promotes adherence, optimizes therapeutic outcomes, and promotes safe use of medicines. Give a formal case presentation that includes presentation of patient data, development of a comprehensive care plan, a summary of literature pertinent to the medication-related problems, and an oral defense of recommendations. Conduct a journal club presentation to a group of peers/health professionals. Demonstrate the ability to assimilate and apply basic, clinical, and social science knowledge in the care of patients. Comply with federal, state, and local statutes and regulations that affect pharmacy practice. Gather, analyze, and apply relevant scientific data, evidence-based data, and other information when solving practice problems (both patient-specific and general practice problems. Use informatics tools when performing self-directed learning, routine pharmacy practice responsibilities, and when solving problems. Solve practice problems (patient care and general practice) in a timely manner by using informatics to gather relevant information (including scientific and evidence-based data), analyzing findings, and forming appropriate conclusions. Demonstrate professional behaviors expected of a pharmacist. Demonstrate personal traits expected of a professional and essential for a successful career. Course Outline, Schedule/Activities, and Assignment Deadlines: Student Schedule: PRECEPTOR: Provide typical schedule, daily, weekly, or monthly, as appropriate, of topics, assignments and required activities. State events or meetings inside or outside those hours the student should attend. Please schedule time to meet with the student to discuss the students performance at mid-point at end of the 4th week and final evaluation at end of the 8th week. State the hours the student is expected to be on site and break/lunch information. If applicable, indicate the hours may not be firm, and describe situations in which a student may need to stay after hours in order to complete tasks. PLEASE FILL IN THE FOLLOWING SCHEDULE: OTHER EXAMPLES ARE IN THE APPENDIX Sample Rotation ScheduleWeekMondayTuesdayWednesdayThursdayFriday1Orientation  2 Midpoint Evaluation34Final Evaluation Interprofessional Experience Opportunities: PRECEPTOR: Include a statement describing any interprofessional opportunities where the student participates in meaningful interprofessional engagement on a healthcare team in both patient care and non-patient care settings. Please include a description of: Non-pharmacy team member(s) i.e. Physician, Nurse, PT, OT, HRNP, RT. (*Please do not include Pharmacist or Technician roles). What the students are doing during their interactions with non-pharmacy team members. How often the students are interacting with non-pharmacy team members. Interprofessional Experience Opportunities allow students to: Engage in collaborative patient care decision making with members of an interprofessional healthcare team with an emphasis on face-to-face interactions but also incorporating other communication options. OR Work face-to-face as a member of a collaborative, interprofessional team, i.e. rounding, quality improvement team. OR Identify, evaluate, communicate to healthcare team members the appropriateness of patient specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, delivery systems, etc. Required Activities/Assignments: In order to achieve the stated learning objectives, students completing the Ambulatory Care Advanced Pharmacy Practice Experience should complete the following activities/assignments: Perform and document, as appropriate to the practice site, at least eight patient medication histories. Perform at least eight patient medication counseling sessions. Present at least one journal club presentation, including analysis and interpretation of the primary medical literature Complete at least 2 written drug information responses using appropriate institutional documentation or the UF College of Pharmacy Drug Information Question Intake/Tracking Form. Demonstrate the ability to perform at least two of the following procedures on an ambulatory patient: Blood pressure measurement Radial and/or femoral pulse Body weight Body temperature Point of care test (e.g., blood glucose) when applicable to rotation site Diabetic foot exam, when applicable to rotation site Present at least one formal patient case presentation, including analysis and interpretation of the primary medical literature as it applies to the patient case. The audience will be selected by the preceptor. Discuss with the preceptor the treatment of the following common ambulatory care patient conditions, with discussions based on actual or simulated patient cases and/or drug therapy problems: Diabetes mellitus Hypertension Pulmonary disease (asthma, COPD) Dyslipidemia Heart failure Angina/CAD Anticoagulation Prepare at least eight pharmaceutical care plans (SOAP notes, chart progress note, etc.) in a concise, organized, and clear format to be included in the patient record as permitted in the practice site. Each care plan should focus on at least one of the following common ambulatory disease states, however documentation should address all active problems: Diabetes mellitus Hypertension Pulmonary Diseases (Asthma, COPD) Dyslipidemia Heart Failure Angina/ CAD Anticoagulation Other Learning Activities: Students will benefit from exposure to the following learning activities during their Ambulatory Care Advanced Pharmacy Practice Experience, when feasible within the rotation/site: Demonstrate knowledge of medical devices commonly encountered in the ambulatory setting and be able to counsel patients regarding appropriate use (i.e. MDI/ DPI, nebulizer, glucometer, blood pressure measurement devices). Discuss with the preceptor the treatment of the following ambulatory care patient conditions, with discussions based on actual or simulated patient cases and/or drug therapy problems: Obesity Cigarette smoking Common outpatient/ambulatory care infections (otitis media, sore throat and nasal congestion, cough, UTIs, etc) Allergic rhinitis Depression Anxiety Headache Osteoarthritis Pain management (back, sprains, strains, etc) GI (GERD, N&V, constipation, diarrhea) Common dermatological disorders Womens health (birth control, vaginitis) immunizations Maintain an organized, current pharmacotherapeutic patient care plan on assigned patients. Participate regularly in patient case presentations. Related activities/assignments may include: Create a data base and progress notes on assigned patients (patient's major medical problem, chief complaint, past medical history, medications taken prior to admission, current medications, diagnosis, laboratory and physical parameters). Discuss drug therapy and progress of assigned patients with preceptor and/or other professionals without notice. Complete pharmacokinetic consults and document recommendations in the medical progress note. Utilize an electronic medical records system appropriately for documentation of patient-related activity. Design and deliver an in-service for the pharmacy staff or other ambulatory staff (i.e. nurses, residents, physicians). Participate in professional pharmacy organizations at the discretion of the preceptor. Administer immunizations and provide appropriate patient education. Participate in disease-specific health screenings at the discretion of the preceptor (i.e. blood pressure, diabetes). Complete an independent project to support the goals and objectives of pharmacy within the practice setting (newsletter to aid in education and awareness of patient health or medication issues, program development to improve continuity of care for specific disease states, chart reviews for the design, implementation or analysis of MUE/ DUE, etc.). Students are responsible for accomplishing the rotation requirements (i.e., evidences that must be submitted in the course site). Rotation Assignments: One (1) Journal Club Presentation Handout or brief written critique of an article Two (2) Drug Information Responses One (1) Handout of Slides Used for Formal Case Presentation Dicussion of disease state Discussion of drug therapy options Individualized drug therapy plan Conclusion and critique of therapy Eight (8) Pharmacy Notes De-identified Pharmacy/Progress Notes Prerequisite Knowledge and Skills: Students must have successfully completed Introductory Pharmacy Practice Experiences and required didactic courses prior to beginning their Ambulatory Care Advanced Pharmacy Practice Experience. Students should be familiar with and prepared to apply treatment guidelines for optimal patient care for the following disease states (or others as directed by the preceptor): Diabetes mellitus Hypertension Pulmonary Diseases (Asthma, COPD) Dyslipidemia Heart Failure Angina/ CAD Anticoagulation Student Evaluation and Grading: Students will be evaluated using the PharmAcademic system (log in or get more information about PharmAcademic at:  HYPERLINK "http://www.pharmacademic.com" www.pharmacademic.com ). Preceptors are encouraged to provide students with written copies of their midpoint and final PharmAcademic evaluations, and to review and discuss each of these with the student. PRECEPTOR: Please indicate ramifications if deadlines are missed if assignments/projects are required. CompetencyDescriptionWeightCompetency #1Drug Distribution SystemsCompetency #2Disease State KnowledgeCompetency #3Drug Therapy Evaluation and DevelopmentCompetency #4Monitoring for EndpointsCompetency #5Patient Case PresentationsCompetency #6Patient InterviewsCompetency #7Patient Education/CounselingCompetency #8Drug InformationCompetency #9Formal Oral PresentationsCompetency #10Formal Written PresentationsCompetency #11Professional Team InteractionCompetency #12Professionalism/MotivationCompetency #13Cultural SensitivityTOTAL100% Attendance Policy: Attendance is mandatory as the quality of learning experiences is directly related to the time spent in the clinical environment. If sickness or other problems require absence during rotation time, students must arrange to make up lost time with the preceptor. Failure to participate in the assigned number of hours will result in an "Incomplete" grade for the course. Excused Absences: each excused absence will be made up at the discretion of the instructor. Absences may be excused secondary to health or family issues (personal illness, dependents illness, doctor appointment, family crisis, etc.), professional issues (interview for position, educational meeting, etc.) or at the discretion of the preceptor for other reasons not listed here. Absences that are planned require notification prior to the day of the absence. A minimum of 1-week notice regarding planned absences is expected. Unexcused Absences: an unexcused absence will result in a deficient evaluation of Competency 12 in the PharmAcademic evaluation and the subsequent loss of grade that would produce. Each absence must be made up at the convenience of the instructor. Failure to notify at the time of the absence in the case of unexpected situations will result in an unexcused absence. Failure to notify in advance of planned activities will result in an unexcused absence. Time missed due to administrative issues (e.g. fees not paid, lack of portfolio requirements) are counted as unexcused absences unless made up at the preceptors discretion after the originating offense is corrected. Tardiness: two unexcused tardies will be the same as one unexcused absence. The definition of tardy will be left up to the instructor. Minimum attendance for a complete rotation is 17 out of 20 working day rotations or 35 out of 40 day rotations. Students missing more than 3/20 or 5/40 for any reason that are NOT made up must reschedule the entire rotation at a later date. Educational meetings are an important part of being a professional. Attendance will be encouraged, but not required. Faculty and instructors will encourage the students to attend meetings. Residency and position interviews likewise are and important for professional advancement but must not be scheduled in time and number to significantly degrade the quality of the ongoing Advanced Pharmacy Practice Experience. This should be taken into consideration when they are scheduled. Days missed due to these events will be made up at the discretion of the preceptor. Rotation Demeanor: PRECPETOR:Please add any statements regarding expected behavior of students during rotation APPE Student Dress Code: The following is a basic checklist for professional dress during APPEs. Additional requirements or guidelines may be instituted at the discretion of the site or preceptor. All students must wear neat, clean, white laboratory coats unless otherwise directed by the preceptors. Students should wear their College of Pharmacy ID as well as any nametag or badge issued by the rotation site. Nametags from places of employment should not be worn at a rotation site. Female students may wear skirts, dresses, or dress slacks with appropriate hosiery and shoes. Closed-toe shoes are preferred in any practice site. Some sites require closed-toe shoes, and students must comply with that requirement at those sites. Male students must wear dress slacks, collared shirts, ties, socks and appropriate shoes. Jeans, shorts, mini-skirts, thong sandals, T-shirts, etc., are inappropriate dress at any rotation site, and are NOT allowed. All students must maintain good personal hygiene. Students may be asked to leave a rotation site due to dress code violations. This absence is unexcused. All students will also be expected to adhere any institutional policy relating to personal appearance and/or grooming not covered in this manual. Additional Policies and Information Student Accommodations - Students with disabilities requesting accommodations should first register with the Disability Resource Center (352-392-8565, www.dso.ufl.edu/drc/) by providing appropriate documentation. Once registered, students will receive an accommodation letter which must be presented to the Director of Experiential Programs to request accommodation. Students with disabilities should follow this procedure as early as possible prior to the rotation. UFs Honesty Policy - UF students are bound by The Honor Pledge which states, We, the members of the University of Florida community, pledge to hold ourselves and our peers to the highest standards of honor and integrity by abiding by the Honor Code. On all work submitted for credit by students at the University of Florida, the following pledge is either required or implied: On my honor, I have neither given nor received unauthorized aid in doing this assignment. The Honor Code ( HYPERLINK "http://www.dso.ufl.edu/sccr/process/student-conduct-honor-code/)" \h http://www.dso.ufl.edu/sccr/process/student-conduct-honor-code/) specifies a number of behaviors that are in violation of this code and the possible sanctions. Furthermore, you are obliged to report any condition that facilitates academic misconduct to appropriate personnel. If you have any questions or concerns, please consult with the Director of Experienctial or Regional Coordinator for this rotation. Preceptor Evaluations Students are expected to provide feedback on the quality of instruction during this rotation. This evaluations is completed in PharmAcademic and is made available on the last day of the rotation. A blinded summary of the assessment result is sent to the preceptor at the end of the academic year after rotations are completed. Complaints: Please contact your Regional Coordinator should you have any unresolved complaints or issues with your rotation experience after speaking with your preceptor and/or site coordinator. You can determine who the assigned Regional Coordinator is for the site by looking at the sites information in PharmAcademic. Regional Coordinator contact information can be found at  HYPERLINK "http://pharmacy.ufl.edu/experiential/contact-information/" http://pharmacy.ufl.edu/experiential/contact-information/. Please contact the Director of Experiential Programs should your complaint or issue remain unresolved. University Counseling and Mental Health Services: Phone: (352) 392-1575 Website:  HYPERLINK "http://www.counseling.ufl.edu/cwc/Default.aspx" http://www.counseling.ufl.edu/cwc/Default.aspx APPENDIX #1 Example of Rotation Schedule:  #2 Example of Rotation Schedule: Week 1 Monday: Orientation/introductions Tuesday: Community Pharmacy production/drop off review, pharmacist duties review Wednesday: Direct Patient Care/ Counseling Remediation Thursday: Drug Monograph Due Friday: Direct Patient Care, immunizations review Week 2 Monday: Direct Patient Care/Counseling Remediation Tuesday: Direct Patient Care/Counseling Remediation Wednesday: Legal review--control drug review Thursday: Drug Monograph Due Friday: MIDPOINT REVIEW Week 3 Monday: OTC Drug review Tuesday: Direct Patient Care Wednesday: Inventory Management review Thursday: Drug Monograph Due Friday: Week 4 Monday: Direct patient care Tuesday: Direct patient care / *Formal Patient Case Due Wednesday: Direct Patient Care Thursday: Drug Monograph Due Friday: FINAL EVALUATION #3 Example of Rotation Schedule: Sample Daily Rotation Schedule: 7AM-3:30PM* *Student may need to arrive earlier or leave later depending on daily activities and amount of time needed to complete responsibilities and prepare for rounds. Updated rotation schedule to be obtained from assigned preceptor. A 30 minute lunch break may be taken. TimesMondayTuesdayWednesdayThursdayFridayPrior to Rounds (Rds)Work-up new admissions, review patient labs, medication changes, develop problem lists, evaluate pain control and supportive care management, check MARs, etc. * Attend P &T, Critical Care meetings etc.0800 1100Rounds#Rounds#Rounds#Rounds#Rounds#1100-1200ICW*ICW*ICW*ICW*ICW*1200-1300ICW*ICW*ICW*ICW*ICW*1300-1400ICW* or attend MUE, Formulary Sub-Committee Mtgs, Preceptor Journal Club, Student/Resident Interactive Teaching Experience (SPRITE), etc.1400 - 1600Meet with preceptor and/or residents(s) for topic discussions, review new admissions, changes, evaluate therapeutic regimen, discuss presentations etc. (Please note, discussions may go past 1600 depending on availability of the preceptor)PMICW* * ICW = Individual Clinical Work: activities outlined below #- Rounds times and days vary by unit and attendance will be determined by preceptor *see sample calendar in appendix A.      Syllabus Template for Preceptors: This template document is intended to assist you in making a rotation syllabus to enhance communication with students. Replace the highlighted text with the information that is specific to your rotation, then delete this header text for final syllabus.  PAGE \* MERGEFORMAT 9 :EFGWcgwj r - Q   4 ౠvveWeWeWeWeWehCJOJQJ^JaJ hhCJOJQJ^JaJhj#CJOJQJ^JaJh~7OCJOJQJ^JaJh\CJOJQJ^JaJ hhj#CJOJQJ^JaJ heXhj#CJOJQJ^JaJhj#5CJOJQJ^JaJhT<5CJOJQJ^JaJ#heXhj#5CJOJQJ^JaJhVQhj#56OJQJFGW  4 ` k y Q & F"gdT< & F"gdu]gdqgdj#$a$gdj#4  ~ PQ\dht}~ͼq_Phj#5CJOJQJ^JaJ#heXhj#6CJOJQJ^JaJh{rCJOJQJ^JaJ# *heXhj#CJOJQJ^JaJ *hj#CJOJQJ^JaJh-ICJOJQJ^JaJhdCJOJQJ^JaJ hihqCJOJQJ^JaJ#heXhj#5CJOJQJ^JaJ heXhj#CJOJQJ^JaJ *hqCJOJQJ^JaJ45$%4䰢rraSrhn^8CJOJQJ^JaJ hE.h~7OCJOJQJ^JaJh$(CJOJQJ^JaJ h$(h$(CJOJQJ^JaJ hT<hT<CJOJQJ^JaJhu]CJOJQJ^JaJ hu]hu]CJOJQJ^JaJ)hBhj#B*CJOJQJ^JaJphh~7OCJOJQJ^JaJhT<CJOJQJ^JaJhj#CJOJQJ^JaJ 5%5!^ z{ $$Ifa$gdbgdb= & FgdQgdQgdj# & F"gd~7O & F"gd$( & F"gdu]45 !]^ᾩjUC,, *hHhQB*CJOJQJ^JaJph#hQB*CJOJQJ^JaJph)h{hQB*CJOJQJ^JaJph,h{hQ>*B*CJOJQJ^JaJph&hQ5B*CJOJQJ^JaJph&hj#5B*CJOJQJ^JaJph)hp; hj#B*CJOJQJ^JaJph)h7thj#B*CJOJQJ^JaJphh~7OCJOJQJ^JaJ h% h~7OCJOJQJ^JaJh$(CJOJQJ^JaJ 8Lc<XZ`dvzzzzzfzfzzT# *h?[hQCJOJQJ^JaJ& *h?[hQCJH*OJQJ^JaJ# *h'8hQCJOJQJ^JaJ *hQCJOJQJ^JaJ *hQ5CJOJQJ^JaJ& *h?[hQ5CJOJQJ^JaJ)h{hQB*CJOJQJ^JaJph, *hHhQB*CJOJQJ^JaJph& *hQB*CJOJQJ^JaJphz{ !$%')*@ACDEFHIKMN`acվnnnnnZ&h/, >*B*CJOJQJ^JaJph#h hb=6CJOJQJ^JaJ h hb=CJOJQJ^JaJ hoLhhb=#h hb=5CJOJQJ^JaJ&hb=>*B*CJOJQJ^JaJph, *hhb=B*CJOJQJ^JaJph& *hb=B*CJOJQJ^JaJph, *h{hQB*CJOJQJ^JaJph $Ifgdbnkd$$Ifl$h% t0644 lap ytbkd$$Iflֈ H$<<<<<< t0644 lap<ytb !"#$ $Ifgdb $%kd6$$Iflֈ H$<<<<<< t0644 lap<ytb%'()*+,@ $Ifgdb@Akd$$Iflֈ H$<<<<<< t0644 lap<ytbACDEFGH $IfgdbHIkd$$Iflֈ H$<<<<<< t0644 lap<ytbIKLMNO` $Ifgdb`abgdQkdR$$Iflֈ H$<<<<<< t0644 lap<ytbbcf 3!""%"""F###$ & F%gd[ & F% 0Pdgd[gdj#^gd/,  & F-gd/,  & F.gd/, ^gd/, gd/, gdQ?n+f !2!D!E!Q!R!""" "ҺҦҦҏҦҦzeN,h{hj#>*B*CJOJQJ^JaJph)h?[hQB*CJOJQJ^JaJph)h?[h/, B*CJOJQJ^JaJph, *hsh/, B*CJOJQJ^JaJph& *h/, B*CJOJQJ^JaJph/ *hsh/, 5B*CJOJQJ^JaJph, *hsh/, B*CJOJQJ^JaJph, *h8#h/, B*CJOJQJ^JaJph ""#"$"q""""""#"#(#W#]########$$$(%3%?%{{j\jG)hKWrh[B*CJOJQJ^JaJphh[B*OJQJ^Jph!h[h[B*OJQJ^JphhcOJQJ^Jh[OJQJ^Jh[h[OJQJ^J#h\B*CJOJQJ^JaJph#hj#B*CJOJQJ^JaJph)h+jhj#B*CJOJQJ^JaJph,h{hj#>*B*CJOJQJ^JaJph&hj#>*B*CJOJQJ^JaJph$%4%Q%^%p%%%&'''''''''a)s))^gd[ & F%gd[ & F%gd[ & F%gd[ & F% 0Pdgd[ & F% 0Pdgd[?%B%q%%%&&&'''( ((l(m(~(((())K*[*d*Զ}fTBT#h\B*CJOJQJ^JaJph#hj#B*CJOJQJ^JaJph,hyhj#>*B*CJOJQJ^JaJphhcCJOJQJ^Jh[h[CJOJQJ^JheheCJOJQJ^Jheh[CJOJQJ^Jh[CJOJQJ^J#h[B*CJOJQJ^JaJph)h[h[B*CJOJQJ^JaJphh[h[OJQJ^Jh[OJQJ^J))))))))**+E,M,_,,,,,, -:-a- & F)gde & F)gde & F) 0Pdgd[gd[gdj#^gd[ & F%gd[d*m***=+>+f+++--------v.w...c/d/e/f/0040<0K0R0S0X0`0001l1m111(2)2/242H22˾uh[OJQJ^Jh[h[OJQJ^Jh[h[OJQJ^JheheCJOJQJ^JheCJOJQJ^Jh[OJQJ^Jh[h[OJQJ^Jh[>*B*OJQJ^Jph#hj#B*CJOJQJ^JaJph#hvB*CJOJQJ^JaJph.a----w.f//4001m11(233 4 4t444 & F,gd@? 1$7$8$H$gd&Wgdj# & F) 0Pdgd[ & F) 0Pdgd[ & F)gde23333333334 4 44444 4оРЌxdxP<&h@?5B*CJOJQJ^JaJph&hR5B*CJOJQJ^JaJph&hq5B*CJOJQJ^JaJph&hb=5B*CJOJQJ^JaJph&h&Wh&W5CJOJQJ\^JaJhb=CJOJQJ\^JaJh48CJOJQJ\^JaJ#h~vh&WCJOJQJ\^JaJh&WCJOJQJ\^JaJ&h[5B*CJOJQJ^JaJphh[h[OJQJ^J44525U5555.7@7M7o7|77777749999999$IfgdQ & F*gd+acgdj# & F,gd@? & F,gd@? 4U55555F6V6_6h6|6-7.777777'848ǰzhYE33#hdB*CJOJQJ^JaJph& *hj#B*CJOJQJ^JaJphh[h+acCJOJQJ^J#h+acB*CJOJQJ^JaJph#hqB*CJOJQJ^JaJph#h\B*CJOJQJ^JaJph#hj#B*CJOJQJ^JaJph,h94hj#5B*CJOJQJ^JaJph&h&W5B*CJOJQJ^JaJph#h48B*CJOJQJ^JaJph#h@?B*CJOJQJ^JaJph487898:8d8e8z8{8}8883949>9?999999ıvbvOG7hc2CB*CJOJQJaJphhc2CCJaJ%hc2C5B*CJOJQJ\aJph& *hQB*CJOJQJ^JaJph, *hvhQB*CJOJQJ^JaJph#hQB*CJOJQJ^JaJph#hdB*CJOJQJ^JaJph$hq h0JCJOJQJ^JaJ,jhB*CJOJQJU^JaJph#hB*CJOJQJ^JaJph#hj#B*CJOJQJ^JaJph99999gaaa$Ifkd$$IfTl,F/Cg*gTg AAA tppp>6    44 lBaqppppytc2CT999:::G:I:J:q:s:t::::::::::;;;<;>;?;k;m;n;;;;;;;;;;;;;<<<㞇,hhj#5B*CJOJQJ^JaJph#hc2CB*CJOJQJ^JaJphhc2CB*CJOJQJaJph%hc2C5B*CJOJQJ\aJphhc2CB*CJOJQJaJphhc2CCJaJ( *hhc2CB*CJOJQJaJph,999::gaaa$Ifkd$$IfTl,F/Cg*gTg  t>6    44 lBaqpytT:::G:I:gaaa$Ifkd$$IfTl,F/Cg*gTg  t>6    44 lBaqpytTI:J:X:q:s:gaaa$Ifkd$$IfTl,F/Cg*gTg  t>6    44 lBaqpytTs:t::::gaaa$Ifkd $$IfTl,F/Cg*gTg  t>6    44 lBaqpytT:::::gaaa$Ifkd $$IfTl,F/Cg*gTg  t>6    44 lBaqpytT:::::gaaa$Ifkd $$IfTl,F/Cg*gTg  t>6    44 lBaqpytT::;;;gaaa$Ifkd $$IfTl,F/Cg*gTg  t>6    44 lBaqpytT;;";<;>;gaaa$Ifkd $$IfTl,F/Cg*gTg  t>6    44 lBaqpytT>;?;N;k;m;gaaa$Ifkd% $$IfTl,F/Cg*gTg  t>6    44 lBaqpytTm;n;};;;gaaa$Ifkd*$$IfTl,F/Cg*gTg  t>6    44 lBaqpytT;;;;;gaaa$Ifkd/$$IfTl,F/Cg*gTg  t>6    44 lBaqpytT;;;;;gaaa$Ifkd4$$IfTl,F/Cg*gTg  t>6    44 lBaqpytT;;;;;gaaX $$Ifa$$Ifkd9$$IfTl,F/Cg*gTg  t>6    44 lBaqpytT;<<<==??aAbA;B$$IfTl,F/Cg*gTg AAA tppp>6    44 lBaqppppytc2CT <+<0<<=====I>O>????@@`AbAAAAAAAAAA:B*B*CJOJQJ^JaJph#hdB*CJOJQJ^JaJph)h(}?hj#B*CJOJQJ^JaJph,hhj#>*B*CJOJQJ^JaJph#hj#B*CJOJQJ^JaJph)hhj#B*CJOJQJ^JaJph"*B*CJOJQJ^JaJph&hGA5B*CJOJQJ^JaJph,h ]hGA5B*CJOJQJ^JaJph#hj#B*CJOJQJ^JaJph)ht9hj#B*CJOJQJ^JaJph,ht9hj#>*B*CJOJQJ^JaJphGKHKIKlKmKnKK@MBMNMUMWMXM'O)OƯƛu^I4- h^hGA)hvhGAB*CJOJQJ^JaJph)h{rhGAB*CJOJQJ^JaJph,h{rhGA>*B*CJOJQJ^JaJph&hGA>*B*CJOJQJ^JaJph#h-IB*CJOJQJ^JaJph&h-I>*B*CJOJQJ^JaJph,h ]hGA5B*CJOJQJ^JaJph&hGA5B*CJOJQJ^JaJph#hGAB*CJOJQJ^JaJph& *hGAB*CJOJQJ^JaJphmKnKAMBMQxRyRRTTU-UUUUUUUUUUUUUVgdj56$a$gdj56gdQgdGAl2gd-IgdGA)O*O{O|O}OOOOPQQ+Q,Q-Q.QQQyRջ誕ՀnWBnBn0n#hdB*CJOJQJ^JaJph)h{rhGAB*CJOJQJ^JaJph,h{rhGA>*B*CJOJQJ^JaJph#hGAB*CJOJQJ^JaJph)hvhGAB*CJOJQJ^JaJph)jhvhGA0JCJOJQJUaJ hvhGA0JCJOJQJaJ3jChvhGA0JCJOJQJU^JaJ$hvhGA0JCJOJQJ^JaJ-jhvhGA0JCJOJQJU^JaJyRRSSSST=T?T@TATzT{TTTU6U7UsUtUuUUUUڱڜڂoڜڱUB$h hGA0JCJOJQJ^JaJ2jhGAB*CJOJQJU^JaJph$h+ hGA0JCJOJQJ^JaJ2j6hGAB*CJOJQJU^JaJph)hvhGAB*CJOJQJ^JaJph,jhGAB*CJOJQJU^JaJph#hdB*CJOJQJ^JaJph#hGAB*CJOJQJ^JaJph&hGA>*B*CJOJQJ^JaJphUUUUUUUUUUUUUUV V V/V1VWVƯƠ{rrXCC5hj56CJOJQJ^JaJ)hbkhj56B*CJOJQJ^JaJph2hbkhj5656>*B*CJOJQJ^JaJphhj56mHnHu jhRhj56UmHnHu& *hj56B*CJOJQJ^JaJph *hj56CJOJQJ^JaJ, *hPXhj56B*CJOJQJ^JaJph#hj56B*CJOJQJ^JaJph#hj#B*CJOJQJ^JaJph)hvhQB*CJOJQJ^JaJphV&VyVVVWWW WBWwWWWWWWWXDXaXkXlXsXXXX Y'Y(YgdQgdj56WV^VlVqVxVVVVVVVVVVVVWWW WWW+WAWJWLW`WvWWWWWWWWWWWWWXX'XCXNX̺̠̺̺̺̺̺̺̠̺̺̺̉,hbkhj56>*B*CJOJQJ^JaJph2hbkhj5656>*B*CJOJQJ^JaJph#hj56B*CJOJQJ^JaJph)hbkhj56B*CJOJQJ^JaJphhj56CJOJQJ^JaJ hbkhj56CJOJQJ^JaJ,NX`XhXjXkXlXsXzX|XXXXXXXXXXXX YYYY'Y(YIYJYKYѿѨѿѿѿѿ}ѿѿюnZH#h/, B*CJOJQJ^JaJph& *h/, B*CJOJQJ^JaJph *h/, CJOJQJ^JaJ hbkhj56CJOJQJ^JaJ2hbkhj5656>*B*CJOJQJ^JaJph,hbkhj56>*B*CJOJQJ^JaJph#hj56B*CJOJQJ^JaJph)hbkhj56B*CJOJQJ^JaJph2h%hj5656>*B*CJOJQJ^JaJph(YJYKYwYZZZZZZZ dh$Ifgdmqgd/, KYZZZ[[[[[[[[[[[[[[\ \ \\\\\]]]]]]]8^9^]^^^_^`^wf j[Fh~ hiF<CJUaJ jEh~ hiF<CJUaJ)h{rh/, B*CJOJQJ^JaJph#hLO`h/, 5CJOJQJ^JaJ#h"h/, CJOJQJ^JaJh h"h/, CJOJQJ^JaJh"h/, OJQJ^Jh"h/, 5OJQJ^J#h"h/, 5CJOJQJ^JaJ%ZZZ[>2! !dh$Ifgdmq dh$Ifgdmqkd@$$IflֈD  ! X|0x!4 laytmq[[[[[[[[yhhyhh !dh$Ifgdmq dh$Ifgdmqykd[A$$Ifl40 ! l0x!4 laf4ytmq[[[[>2! !dh$Ifgdmq dh$IfgdmqkdA$$IflֈD l ! X|T0x!4 laytmq[[[[[ dh$Ifgdmq !dh$Ifgdmq[[[[>2! !dh$Ifgdmq dh$IfgdmqkdB$$IflֈD l ! X|T0x!4 laytmq[[\\ \ !dh$Ifgdmq dh$Ifgdmq \ \\\>2! !dh$Ifgdmq dh$IfgdmqkdmC$$IflֈD l ! X|T0x!4 laytmq\\\]~m !dh$Ifgdmq dh$Ifgdmqtkd-D$$Ifl0 ! l0x!4 laytmq]]]]{{ dh$IfgdmqwkdD$$Ifl40 ! l0x!4 laf4ytmq]]]9^]^^^^^^^^^^^{{vtttttttgdQgd/, Pgd/, wkdCE$$Ifl40 ! l0x!4 laf4ytmq `^a^b^c^d^e^f^g^h^i^j^k^l^m^ͼxgVE4# jNh~ hiF<CJUaJ j[Mh~ hiF<CJUaJ jLh~ hiF<CJUaJ jGLh~ hiF<CJUaJ jKh~ hiF<CJUaJ jKh~ hiF<CJUaJ jJh~ hiF<CJUaJ jIh~ hiF<CJUaJ jQIh~ hiF<CJUaJ jHh~ hiF<CJUaJ jHh~ hiF<CJUaJ jGh~ hiF<CJUaJ jGh~ hiF<CJUaJ m^n^o^p^q^r^s^t^u^v^w^x^y^z^ͼxgVE4# jUh~ hiF<CJUaJ jUh~ hiF<CJUaJ j[Th~ hiF<CJUaJ jSh~ hiF<CJUaJ jGSh~ hiF<CJUaJ jRh~ hiF<CJUaJ jRh~ hiF<CJUaJ jQh~ hiF<CJUaJ jPh~ hiF<CJUaJ jQPh~ hiF<CJUaJ jOh~ hiF<CJUaJ jOh~ hiF<CJUaJ jNh~ hiF<CJUaJ z^{^|^}^~^^^^^^^^^^^^^^^_ͼxc[W[W[W[WD2" *h\1%hj#6CJOJQJaJ% *h\1%hj#56CJOJQJaJhiFjhiFU)h{rh/, B*CJOJQJ^JaJph jGZh~ hiF<CJUaJ jYh~ hiF<CJUaJ jYh~ hiF<CJUaJ jXh~ hiF<CJUaJ jWh~ hiF<CJUaJ jQWh~ hiF<CJUaJ jVh~ hiF<CJUaJ jVh~ hiF<CJUaJ^^________gdQ$a$ ____________Ϳ޻)h{rh/, B*CJOJQJ^JaJphhiFjhj#UmHnHuh-ImHnHujhj#Uhj#hBhj#6CJOJQJaJhj#6CJOJQJaJ 21h:pj#/ =!"#$% $$If!vh#vh%:V l t065h%p ytb$$If!vh#v<:V l t065<p<ytb$$If!vh#v<:V l t065<p<ytb$$If!vh#v<:V l t065<p<ytb$$If!vh#v<:V l t065<p<ytb$$If!vh#v<:V l t065<p<ytb$$Ifq!vh#v*#vT#v:V l, AAA tppp>6,5*5T59/ /  / Baqppppytc2CT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l,  t>6,5*5T59/ / / /  BaqpytT$$Ifq!vh#v*#vT#v:V l, AAA tppp>6,5*5T59/ / / /  Baqppppytc2CTDyK yK http://www.dso.ufl.edu/sccr/process/student-conduct-honor-code/)DyK yK thttp://pharmacy.ufl.edu/experiential/contact-information/DyK yK ^http://www.counseling.ufl.edu/cwc/Default.aspx*Dd 5%p  s >A?Picture 1"b)G?&b'ɡb ). n)G?&b'ɡb PNG  IHDRȓsRGBIDATx^ \T ,|)h G3?r0+j,ф$#D!>@A@qEE̜]X|܋0g7<~7 @h  @LLXh@ FLX S @ &, @ #&) @ @ V @ m @@ a q@ 6@ a0@ `B@ 0`j@\ @0a  @h0a5La .@ @ 4@F @  ۽@ V" @{{j@ $&* D@ @&&l? HLX T @ML=@ 44 ݛ[P{ @h 0a5Pi 2@ 70a@ @`j@d @to`voC@ @@  @@ J@ н ۽@ V" @{{j@ $&* D@ @&&l? HLX T @ML=@ 44 ݛ[P{ @h b-Zk" @t)xa2@ Z: @KK*@@@i,P#@ ȿD  @@ A;@,@ :I@ h`¶D @3 ۙ, @v &l;@,@ :I@ h`¶D @3 ۙ, @v &l;@,@ :I@@OӐL=)'!ֽwMz<Ǩg2 oi;9ߩG7;eУ @Gcc$_4x&z~`>m|r#Th 2Pɚ/vaF8Z_hu>sAk"6ph2=ݓ:rȄu|7)ڲ l.zWxRAk*/KD= ە H饣 ifz: W3|fڃYQU|&1gC^ۯ^F[9=^X2d @7>;C_O|`6='9Ƣy-и.o-rSi-WJ>xT#*\7â* ϊH/c> ;; @w!&lw4@}i_æ dVKsHߣV; 7Z}u܂+_z-}TeAU_ ,e,jDyCS @5 '@ (':džy;=絩#Lw&=I͹ZrEξ6CI-7CYQh~陋Ţ%x9m@,6&47]60{A?G.0@m+o>ْ[K R)ct{POrga A=i03K%Ug&Y0`t?V?f=Vxqi|Βba:$̙  wTnQ3~N$?܌ h,(w/\I^v(p"AG|@7"=lj/]xOsO׌[f)_џ\ߺ:msu lSR^({KGt1گ(mG.o`X-[f`sO\}c0 }tاml}? p?O+1Oh Yr}u3JappوBTH V1%: D 3q,^ }549/s+alc1m>9 z =g]P# 237TE=/|/vMPd=/H绛[}0l"[aH{-3>zhNE_*l5mT^言>KDz&ɑmf7}#MO(+Jg%5pVi:d*16:=uΫ?w~3u Iiٟτa8Yiȧx~qxFcmK!Y+cN_!}8O&7pTYLjcEam#)-mˡc^˞+8fhCd=s:} #8LzpLQw 0\`mo3@πNKD*>]ڷ…ҿ mjW*>ڏLgn0O\׍+cE.fHӚ3ޗУ'/0FWҐ5õǶ+L`c`od1]A]s&4QQ4& By?{\8ѹZjIFs9d5fٹsW^1\57%-(7DFsgٙAvmڶmTd!tE ӏ{W0AgTy\фfj`vxN ~Aܙyd{[N4B+je4Or"D`|^"Xq賿*28cGpəl+@~u /I#d r5sqTg;+jlE*9 :p]vr\E&\ 61ti4P9 +2l}w' (uЪ[vej٦KD)mBzF1TCQ$q.[CNzyVÌl\c}l,RLT8e\Zω!b-&v>xv|~R275\;X6W?*ʫ$X\]qL6Ԥ`/u>Z# m-NLގxPt,G!t'//?ԋj]}gEkiWsip qY|ROɈhk̏E6ԣˬۡRZdoYB?⋚:b jaMWƳVZK;b'Y_<7WC}EYu'a73{}SVdݷ\NLXu^Gcredk/k{-*kW+ >[XZ-t_0n0W0֗Ӷ7;//-Y?;V V5# =X'NY}8 |=8Z$YY*wjM틶s@ϊv qWؠCFG; OUm$y{$NO,K ؿC=ېc۞b400mjܑIX#( !ЂqsRP#e|Sׅ'WRO:QO]-;?Jގmw; Qk{JzF+Z60gT "Jigp{W>%ƻΐXO> {lJa |:hGXt Ԟj"L-ᒧ/?Iص"d)EXP&_S{X=H.=jQ" qRKV2g1 %z{xᳫȜZդrf۴WNWd&72}g`lhf0C^gi[K_`4&=z@)ZMokXϵ`x%7b41$@kkjJ@xZS>6³9D,}uÇ [LN?\p&ΰ I4P٩d(t!7?4TtRlgt.j{?#fYF.0&2vh _p=].e\B Y|[ćKGJQw6#&.C_7ckA6anUdQJQ4s?uKFj!ˁ) 1;V+*d#D_8z1 sCV;uxz"4'ؐPnG4Un#xM%УQj骘؎:@@S7Sl؀;G"g*+"b-Bn~Z@7ჶ^B\be"A~AO ]*IOnz>B# .qm}mz?EbO*O#Pt~J*+~ {eUN%P./5bcS $ >Ҳp-31ewR5cj BJ^+k7쎼*<vb-x'YnSo{BQڍQ]1KF׮D{X~mFGrg*zQWa7w͸^~J)OkRooE~ާ%xTȰgI_fA^uI~EB&X# nLTE8埽=.:E #̞='ҏ#p9!y!\E%د4J3 u@ z/z@ h+$h+Ax @ 8 @} @N&&l'@ JLض@ : @ h+0aJ@ d`v2p( @m+Ax @ 8 @} @N&&l'@ JLضP@mG?>x n;ܓ,@N#&l@ ڇ@FɜMv\ }]\Ǹ)e1SP ']kִAޣF5w~:#a>iluV 4:FTv cvߪ4t=υo|^ޏ^Y{'M4l6&xX_7x&zXbK>߹Z{((3ɃLi2d>ɼ⟥i)ymwu'1+ؔs7wa{@;SBK ,]4p'W,+f€^+.EM^5]X)ۓp$ݧ@Mh+Kt m  &?oDeK׈}Q7cWhy{Vs Y\Rt希_I>fQ[y>گh=~s;H7^eLLנѶ+Jۜd-~C1J6rTE>ÆomW\%SF6C_(0P?=XPe %–f`{Qگ-_"cJJqC~f&o T & hQ=lsˀ3- ɡzZm ϻp﹪yKc6~|EμyFL ʤJ6!kBނ?EمH;k6^lo|{*-g=F?#wķ]XM$kcVC(PY6)Ǵm<@_POlfbɽ4%L;i#kn+C׬QMQPJ22)Ls| tL&XɌ_IN<]Pʨ6T8i X @'u%.Ҳe~uEu8k:rآ;ؔ5DLw4TFsYCvl+FLm;mf у/7U[,ks{=n.F?} /A)]%yKф"A[J47־PiyZy5Sp-"Nӣ]]([(mé:}v;g|Irkb%bj@i`B @痥T5PV9~8tT/>hxl$S]uIq S,uGXP=|<Βm0\moT |I\%m$FZ9YY&b(v՜q,!]E8xXN*s'"CH0\6@'h'( mĖ]CvxĤ0V[f-Q(w#f"U{M:Ջ8hOPɫ> sљ>i1Z|i;sRJ# u0;< t1Xpsu[sjъy c >$~'k9cwę㫿n%+ʮ9yo+$)7nۢ[CWaв7G]4\;wulb.8@ 4xa5] ?估uh.?rw%Pƿ^`u[@ nK"wcedř詧m :<2P @@)B@  EEh ^][L'%[KX9 w v]CM`¡oF֦_sbs!Ĝ~m+\x/l[@ II@ Pp$@ P*aD@ CLXH@ 0aU@ ԇ  @@%`ª  @0aG @ JU $@ P`ª.@ @(`V!@ @ H`v$] @ P!K @$  ۑeA@ @ B@ ILΤ e @Ł=zh56nN@cU&Am§/5Som&|2]Tլm$@ P/`ª>@ @f ,"H@ ^U/}4@ YD @@ ^i@ %&l @ zV @4KLfA @"&י̯m h74M-QM3kIڣU_kF}J[ZSCB˾Fc@g1n +"$; <]IƚӁf}|8v ؛-QǶZzj~Z" lml3aƆwӴLHr {H2?gP{Ol56+OI4~֗ŮlH :F*6{5o']٫[{ݼ,K;ΐ @@ ׊8O( dԏ|sxڄʲ LO9ZiI@/9ܸ-Lj`ege_/%e@PDi wň[A3"5Ult6[u:N_%Q #/k3~+4! eDkMo^4j׿NY[Dfnj :ˆpeUMAU\GCCNHo6=}CTY{492zӥd8FBR{Y~asR^ֶtG28DjrG\O tG0~G,3wĚf܆e7W\ n)1BX[FO_uu7ePSi*Ot"J0>+<(OoViBq۽%OAydn9% *MKbF&"YD;sU/sK{^tpwVGi+KWIfo{zVv:X[ۼP}=)}GD}_ .ϒ-RhPe^nzVyYu*˖sF ģx{At {09hŭ#x} ! 4*(?s@3>:Ύe'y)ڢ̧q2Pv?Eg8+x|Go'h$ѐ ¥IQh^|G;%lf+3 oSe>Mz[ޫ?|݊ޑw}=fl:S*W)ZP~?j1k6 KvҪhwQߑ|ڞMf?wo%f&G V|kdhe 6Ƿ%t$ d^2/zn2^ap<ҘۧO#?E/\RmFwDVi#z|g8׈1iMyc xtX:i,,I巋dKr2aϣo̧o嗟p"&4'AM(|. r˽LOV AXDѷٹC^iǭDzQ셽zOA؎I`^%0~K,J%0bd2w$T`S~ēW5'ב^֍Ojwm6D쯏FP%|bWsa&V13U.ӼEDh0~t("Ȋu'$EJ V"|qT79YXo}G)*^X |U cG(TbR߾z{aeFU)qǐ>nW2ike!ZlWi^ /D8l!{u9)U+fN# HM"ؽԯ2?G8tN\>AF>8zgm# 7KPx>9K( Ha_B<r@ɷgdj}Z}DYQBW: \PpFd7ENk :ZŜ[t7N2RɭT]$%ސ4΅LW쯓t 7]N~wq8W'UlA%A~EU݉IqY'}|CO2MJ+8{VI>KU(} ݕm)2຋. }jY#ˇwQ(}zPWoܥܢQ}^nRM?/":q>) .`ʎdݢQt` >VP_Wyò'MtP[^q*S挥0QaZjS; 'PKV+h)BG ^߷4t@ mS*C4rLXZVGdRlڌA!x5+2p^p*6(dA4&?J2oFSh$u0 "(9uC5^54kAb݋?/zɲRYj$SCH!/П'rP K+tiæ~xG~CuVx 0/mPs3R{TWS2U5t=cn(nmƎ%ftWp%:caR}RBqmn*"?opi{D{,}\4uLҼrLXJ0hWdJLCI*XS=_2g2G2bN'eUnwȳڕ75rScB&a{prB%it:g&zCބY% KCP]vEͬPIQIGa3\ qJ| _񋶠39wҎ4+kpa374Ư`ũd-CK *nH )4)KC>>xxxe1R鑇BV$wҤnM@E,̦]9%*؝:jIUK z܁H|susP dm[r]T'+-U"GcC*>D:,M+yÈXg weZ2vJwtGN,u.  !XMSlEb Hہ'wUT9@e#8 *Em]saeiռrGH@,U2_yX#?vu^ML%c&e1,l\wCtJ%ΧR|7カ1Iqm 8GQD͓>$<w9oRE!ZT'vp9?>(ꂨxNHhQoNL\7o6Q(rKP{!OD0~<96ڇQw\V}Lom7kX,->@`rĄHtuo3M{Mϊ\%〢ۮP*+d^Vuy^vWejjDEQth{Ѻ@[bzݑy)vŃ۟թޕ]eUx:}eI;P-4T1z$uƒ[ǭcy1U>]r^z+5F5\k] u/:@//o:C*T>J*&l+O$t1 䂤XE:"T(_T% uK6‹(n+TfhQ KӚAcDL9]C ({tuPz*^sv} @ A`![ @"&lG|@ :@ (`vY @ A`![ @"&lG|@ :@ (6 _ @ fm3B @s ۹4 @6! @%&lҀ@ L@v6899us6zoN-^X,-Ime,koRFFzF>]/Kj{B4<,/)Z0jꥇ%ܡ \Ϗ38qZPAqW/`ܚ[P1Mc}z"Y[ؓnITyb]D7 YJa-I.-n6eҕ^šCIHG;JMk٧F.ƣ^jj##Eo^`Hɡ^Tʎ,%ONQS[dyIvpu5%VdxOOQ%,Kv\kT3sKN諾J,ك g#CS&l\bLS׽yg(Aq\saA^E xgG';.I,PmXw`,d# cr3w{yGW}>a]B ;Gk] ';bN*(CvgJPWxܐ-ȧA/dz+dւ}4<=m V(/5Z闋) k-Z *0 [l2VG |I{dbڔRd- ^*H+Yv=:cq *M ;Ĩ(Ы"5!ZQud((P-S-)@fe|PZ'\Ӳl3Pfz<ŕY<~xlggzj߇c=m"Ι2ziyZ)Ub,|ҰCp9CB;[ikA,AJ g\("c3k,mbH?ij]/7c:0>p'NE& (8|:˂xOR!UIɟ;>maگ'ied\tORzN+==M`poR2ZT9|ԲDW\Pw#1*eCuZNۿQ=iO2E,g'lVkJzB+?63sǛ?'P>, v%Ii~ y6ThFvl (RYÒmW{;&d .$GET.DuEy)_Kێceq n^@GPWa.r/9zEܦǒOSUܑ^:S\J 1 u5‚}j٨WR=ӽmuvcGr{ ;AJ^3G= Y==_b'N,4:W/B#iYwPra5CaH _7΀c7ޛJME4^^2\-\%k- %l'XvNdɵ:R%n7ɑ 8jh]={;mЧln:DDYafjOo)h)=db-if|ojEk.imvD7'WkwW:2[ͻ'q, kGޡze[ -#E?Ĉ&ϗb(?R݈.ra j p Jڹ=ziDr4 4<E hdG"V Wm1F~M eea,9+uq!~Q){x"?Ĝ ui.ΓWGQlzNqyA0#i?51%{p'+d`%Hn$ %FF+3d9ĜŸZ6'HOJ\T?Dn }=]35Jg=CB,B7^;Tz,o"JdbW4xrh˛#^/%wVN%SSD!Bcۓ6͜Pw1@E[%Aꁞ|З7%S(weoA%5c. */'SS̰T"ϴ{gqMK{sxr  ۮ֔B WOjzғH'5CB3lZyPѢ8.Bߏkϰ>l2/q~ $bJU$/HWk2H {-{9L-,\ p2ΊB&M gG\E)ƚc-_ƠCbZБ "}J5EʋVidcZAOӯݕ$ӧE^Eծ`?*irvylȐg)"ȄvX}Gʾ Y4JcRNWV& v[adPL[vd%U$@T$ iӆ_Up ؆c8,# )xT5v>$U=UhZcF`¶&n*7'evuD rk-!t?CGi#(ud vJ(vكoAfPu8-K-7lqmFXy2jbZY>+ ?Ec 9H>ެVIIv1ImG4qPGu6Gav-5YІG3E;uK`¶/qO&WQrPﻁ$\+bڢ ՚Zi0p\~6;wTq1䀅R8friRGg Ovы=x;VK~0EZGU3w'-X 2dYN?ٸ"˽(<'gpDL^ey~ǻ!jQL^yZ2RiplЎKZpw}^.^A kÃY3Vơ#QTa# :,MvOOc(\b 7LFB]X:"NsZPY$k -~4\wt*j5ZTv@M_8 y_LK߼\YDi8@?RաQX$)ks8EKG?7.Ϣ.a,AaŃ І0ک-rSc2JJ(Nwkoz{9#/|01r1RMDauaT4ŇȊRd=eBpᙙ( cZv`i}j7Y;jj@nh7R9ww5ΫV( Sӷc]t5 3;|`CgE@jJ7ʚ%Kŏ\`ߒ $ .E]},j 4B}E'zAZ*$@KPx2hTB9nѵ @ rCnjzzһ!Ye욥w$,}@ *@0A" @!&$@ P*aDlEr"<]>"UT/|ԃ] XN#~?y$2$QLrCiNĎ˹zPtTmf4T$+ `¶I~N@\;B@/}FK!iI»@%# >]!jŜ@/8ofRe{}>]yY|}قME^_$d_(agqݪCyR3S,mN[AW':ӷDK]Ԍf¥Be%?h hB4I=iGy bkfxZ9z:cH#*@zo٤ױE *dbZ;tA }ZZ/U%%(ߙU5M_S\0?O>q=3~4Qc%^dFƒcKtFVMTǧlF~M zR߹įo},1]o0ڼ_>_Z0tzzޙTBlތf\Ϗ32> ogmKЕz )&{a[[2w 7/[0cP/*`Z ծeT@l)ZzzР}/gI9f04W{L+^Cs7RVƽ(]+N#~n/uts@\ o#S omC]abU9{}|֢ߪ9ڝX\W`,CBEŽҮ%zT{`Տ<x`oQRç/)NMtqv4㷣%VCwgU"O_t."%_WP/]u}<NRB}LV\^>!>jd*O>L ?b+(Qf( P"uİU*o|}A AFqUa;iڒ]> X.vgbuy鑊Yk m^NK7GmOtڼ,"k#S:.OyBVEP{9(n ?HF8C%|!ESX:/+k;=}ӾRU|T.яY^@/W[|ɘ1fY *A}d̉–,jZ{^z+´\ۙv$8 KqIJ|F\̎LA:o}zrOog!;:s_PhՌ=.U'Ӑ ׈Ec-iSyrFRwM\ ǀoBgYpIHʤ-R҅lȴ RUu]sSRoQB@Py9өvڼ]Q# 'amsbLz~JqK>qT^ylI.G oQ{~H6IHIOX޿ln}Zn (/5vsuu.VH"]i)t45\bd/c +*RYKhU(e%ڷ2<"=#i=єG6({m[-q#Ib_WSQ;Eb"CFz[cg=؍RS ?Yq{Gr8j䌔~B.nC#W3Mys"А~~~ӎ͵Ⱥk)\&0Ѻhno!dd|/V\ir O}#w7g"MDS/6Vߗ{Z_:YfWD_Zel;BgQsCdQqvO<3=#%>P7rsc>nۃ $%4ooM ''E% Œ62kZ:X^lrPwgC;i(Zd2OYAPu&J3#'E=/I=g}:vgEXu,G9Zchw,EWL~~0FX|xο{-r5\+R,,u.c e Ouz'ߢ X>w]kw#P~};ۛ?Y:V˷d^>{X.'wƑ?>+L=ŒCgO=W̘3sߛ;KyKiV۶Bp[ʳ!k?, jx+QȂplݼ{fHذ8T :=v#%>k¢ذu5-9nBY?m;}#P V\Ϡ`hX`=Ѿ\vy4ZNhY!ā-=<8Pt\oޫ=ncJ.V  F Y==_GՓ86/hYܑ/bÂEC) J;4d, ")a۔1+*pK!pYeHB&8 ֡t-㆚!0qвñCZ"YtSmWV>+3cܩƣ]q,Vj&pz}Z"dcp'* jE g`䃿ij KWψWS[GǷuLؖkK+KV򳽅1A 32O#Kqm{ C'0/|meG5<@fXP{s|a?caJc>)EAgc(LjuZRq-GԕX_D_ybZБ xa+vl8* #Ԋv6$p#4ےW<Vq؇n bUM@W8A)+7 yGwFho.~"=i02X|qK/wzy]G`X9 ڝ)< ]h1kai{q n*/eE1VoM=Z%ޖvvTEGJebEQQ@I=f='K@qxDt 7) e(6-e<ק>bߡD|'Dxt]${cY{#s(j#޵6g:;tSgy@H p\@E>QZ>&Z!'msP}ؖvS!%ڬhG`T!<)/(~wq"MuzYns=cq:DrlY:-lsx#νxcPK-E[PyK':X5x:j~T,d/|`AKB};J|ŋ>Gt$5Lؖ*DbQ0Wzt>U(ޥ..Rlys$XN_gj7a9z2\h}?Ao8z_};.).S'AgQK-lzQOqY$C]wS-vqyi.jħ1pZy~^+9KB6/tPF۽\ZU 5~X%{rsiWgզq'(9WH}34k_++~YKqݹnhyzJex*"sUK@ J X$Xhi,3Bx7D@dR9 |?cYS. 4rhzOt v%DlVOFҢfN J0]ѩ{璡~l.aUh;'_(Wivj,%lQM3~{dCOh*ws-W9@&''6IBuJcjCBt r}fPP6dl*vdɫѮbfFwRPF l]9wdP<BOSӷ׹[ ۠h~f7ՁiBrDwE#hoWQ::{ߠǁ9u7_Ԇ6ٯvw6UWEYDt&[ډw >N,jeµri)Em?Bz 2 |2C@@mt{fC;!w)|IDp^i!.D,{T#~EOBqwڏ:_PwH@CܠͶcw W@Us@H @ $P $@ P`ª.@ @ &H@7%N XN\CdjKLXU 'OwtKD/Z }m ]o5Εb n@'nl)!>jRl;YNvAIJ-T|j:nm:ۈŌ*]x([7   fU38@:^Q~7=:IXT۔OyQg.V֋ŶqzT=rԓ)SG6rJ[X}x$@!&$@@V8JjxPC)J@(77;xo*16a;LrN@:k"551))(755"n&l=//>l5 Ѝ4T"ɇK$sLD˱u榝"=4E Vs2RۍCU'N&{sşD\»r@\lcd63zq^5a}X^r"΋X*::%= ۵TvNC˅ T#.㦀{ۑXЛ\dT@'vʔ1?T:KKP[l:R$`鞤 Iڳ# ~s;/R6\n ~T^Paacگk 4KL)?F@p ^>ANֺHtxW`,u<Jqeq /wg-PH%t{rS) 0u%УQ^̗&0: wur`Ĭrg1ex 5"1{7l)7T/ pt"AqRDzW']jN݅Cw']4լ/FlV,HP&[_]2\,~ PJLX U @' Yy:0|B\g ;:1Rt yX>a : O3;9AR" @{{j@ $&* D@ @&&l? ^&^s"A9U;HY&&l xy)^<r ؝)uN-:WZjT ~Y +f.lR$^bXfDd4Uud V#Wau od4";e⊟@YV$ 䫐$@IDٞ&d:kJE?8ҘO RF@]LXCcuxV{Q"TWݿaWwtRFT߅rhxP]+~&2~mku5%VdIOQO_@@m b4/KΦ\&[s(kπbP>,)⾹vkuAIl$.G s?ܩv̰8#Ua s01 ;v) fI-1Ž? B˄N9q:媰^ULQ T,SnÃkiq<):sM*Kr~z?d͋wtƛ,\@/K玱MaA^^Dq2 "qiJ$Jŭ{)؟mXTOH O.JDתdhD=R_J rɠ\<فǯz~ /G~9Y:/∿3~\Z"E\LW0[fvcf W9',0g h94 !ńeY죎~6è1mTܺXa;xОʴzߧk9HKΘwWÓEԥa9 ٿU3Ӓ8F׶1G4ܡX%TZ|6/2Hu\lF gII]͞dZ޺?V玅S됖陲 mFR9g&P-h7WHH1zsbъy^T+ZסB1:{vdzr?Qi?vjE6R*b{ˣSt@pYֽqҫx<ʏ) }INOOX?9R<2<9d{)IFz\ | ^;:kc߿={tW^|j>Mm7\Q~EO }t1녽D'EfG~rٓLt4$$'V #rCsVqvO<9u#7'Wg~+!=S7CGR@%WN 0@]vj  ]AZׄ%ב\v02ݼW߇-Z3QBd(Nln hy\~H+,A-?Zc9"48 \2eQ*U],uʵ ZrBaԢӱx5%Z{²$bQG^kv'A-^ JPv=`! IBX\~\uYPfJgUYU?};Rbzvo'bAVмɢwrܢGr{cg{sqP~}%q>KͲIo'ݸA~(D{9QXMڂz,!mLYsYk.i(Mf>Eڍɥ+Kg ttgNj|C4RRRsg岐3xv#-o':XUY\ѷxn}YȜ!FƈQ\!#-KK)׮ !rW E X:i(+i_!&,QyA{xhKb^Lng:44}-PV/y3&/pAiQԻg>dEiʳ^#yc B h=ґ REbU*lq 0v($ZHw=p 2QXغz:<7쩚0/jSYm32PXx+W`l滘Bʒ4Ww ҎœݽʝM;T"i %/ks sx{]mO_OW"Ɨe9mkkKN79 dʼn|ԣD?sNÃP.ayIY&&E#k+/p$Icea e,!q5Kv8Fbc3~KJX]AxjY/h=IMze`^QPesoH`/Hgt:zFܚ''-8v㽩GOAAnW -T9?3,>P^2ܐE[xPˉؑl?Hɢ^.7pxs^]dQd Jo]e+DX:[YzF EkorO3Žg.*SQb{Y}MmLJ"vEj )Z\y9yzp-J+2Q*Xh!/׽q5RFkB;qP= O[p EQ^|,faM,ss̏?j-!yXƺp޵ȱoy Or~ٵMUKB#_g闰M {F§yU+ R 'Q*WfP{rmC?4c{YxPNuEsUrɜN}R?W{L;x-\"C,3JpN>ı*p)K "VOwpBZȣ{$XFi닛6cޘn ǁ^K^. XnK jp0VPsjZ= plotH{])o2jZy}Tu`^tw3?6.Fw¼]ߟр o338ɥA^Γ?:k0}hUu]:2ud}MTOߑazYģ)"P&Lf U-+wB\Xw!ܾF[[З7zgD8庼E'y("l3|ZYVɢ/ ~]?)_&g'|şW΂ciBv@ۨ* @ ~ ٝ˹u䌤=QǵlLRTu澠Ъi{\Nq0bW&Z|s7 g"l,~>s<߇S%5|t7??5gpCRq%H8Y w/}&yQJ *~ۂ''GopD 2R_gώLO1>) ) q ,8vCyB{슢INOOX?9P"ϥ*ϓ3~t鮼|l*8VA[7o"SPnnvu;0a{  @/D5J~ ?^1ܞE }Nŧ"wP^AN;{[¸8`w):lQV\Aijl (7тWS[C]RRtL8 d&,AԳ+BXjHO%/U]zϟBVO4W$dwcб,W># kL$|?GT+i󟱹NhE,Qݕw%m,Ɍe{>R⎝=Wm̚?bL^q9YCv-3gOן-q C   ؝<&7t,> {xcd|AhZXY8: (UrT!&ixX^R6jjgjX4:k]LHZ4e$W[xߕP%/!$Kיs)|_TQ{٧rĻ1MbBP0XP ?~~Xb!Y)G_P,1]+.ުhz6a 92o 0/jS۷$VimIvJv6隖]|'T\BWAD $d@%`ūkxPC'G>?_2v%ExW}35%GKh^=:zF\?CM2qEqQ)xxGޒ@XJh5Pw\Z)RajJZ6_7T?/N9yYBX&k(LjuZx]sHQ^j1haiҒh?SiAG._IpC!SYiYnY%9WxEE%ncGfee\KvI@ql!g 47@T&E1a&< <ѦCGi|/׽q5d7 yGwFk݃oA圿z_@C 6@;痈\ľɉ'h+vg-yE EHOJ>u>Pz1 D9u,'kB5QT Fb8W!~<54:  ڝ)2;4%=?J@S"FFi rv=,iC'8{̋j7HނWqڑMEءŞ]d.R(#-ތ]hߗx/*qÙHOfKޥ..Rlys$m8w\N<c=g.vwI䀤; 8OPs4K gX:v~[ wݱZw'qwBKi ?BeG/ETK.%2:5:@FUlkƚS7'kֳ7ґys=-wa}={s{r\+)M<Wx{벃@h0a[Φ\&[s(kπlA |<Ψ"!x+CN:tx" İd<s88P0ԇ /DZtvs@\1v+y⸏_+yŽDrXXFeoŒw+uW\KOq֡FaNEսb޸>5 !D!qc=I I]t>ZW)R{t.c'+Us3üp 5 YYk$Bk ,'"fu@JLVh0*_>uK~;ӎ?vUu?Xu\ƴ/6@V͈NNKRu2y]_ke͡$gXT߲:z*nbyLnHg{sl_dґ ،$魨y7~mh3ҕ95 cԥ 9iA)7 S5UIc$`o^ac=yօ,$d$|sTo=>{ХFsxm(⹷`Eɴ%(6/;as*:w U@tM`¶B,g(m5aJ \0giyQ|*r5 s%+΂EXu,G9Z`o456vu7тWS[C]RRtL8 Ĕ5ބE\ę8  2e=ܪn+* ,KO"%䵆䉵>+.'Z׶!(>;Z4w:vtp&%ϑ#|$օ$#6z;u;MUQ9 ZJ=KM7]sPwF(~M  J @t-`¶J, crCWS  rӸĬDN8I ńCudK})-Ⴑ {㨒+LAayI W_Ož}\}aخ}Rv1!jєy~QyA7=) *ꡜ-m*:]\;{<Pdq# U¿44 7b]`7$;%BD#=U~TC]rBƆJDSǺ?_2`݌-R1Ajo߽͖C$%=&:g\azTCYޙǤ]I:QjxR[#i`T6 ʁ@+0a[&>P{,P5I9>QnjWA=t-_rWCV}*={tWh4ԃoA圿z_wڇ" -Ms s~uluOj,Wm9da6pe1O.-/$c8Yˉ:u!"M;>хHCZ\+E)ݵ7G7dCqҍ!je=`+#Q4F=t9V{ɯ;P|W_Aŭa E-Oac6 "@t)`¶P:̠֯-rqv &8O3ag a/kV^YgXޮe9mc@gyQ #4`Z[Pb18}"5vD Zx:9ploF.\ O+p_q}M`18˙dmR]op0wŲƟ3}F{!nTVz vw:gN(@Bё!gu}I^^Z-m8zR&GW[R@؈>]-S#az^܄@On+O"m@ Mz{hF:A쮦N@E5_5^;H_filtzw^PuTYʀ*ˋ KD.NŧY3%* ɀ@h0a5DQm9ŇtOxY[Q^m=e"z2 t *-= R @:aKq+zWUIJ:T&tQuwR'h@Z @ҲJ @ V}t @DLX0A" @!x; @MLԴwCAݐ@2tv;WC A @ zV @4KLfA @"&z@ h"@ ELXH@ ,0aE @ ԋꥏn)̓[f8l9_-+݈@-3Ѝ Upp|`%&lyj&|m9|_g.^3xQh.B}An+-@&{\d،| k!ȉ߽aɢb(_zmA@ig',0EkmGYgN'v'朋<< Z s'/r[7J$l>BbNoTmŠ(!~wm!_DNSo{;{+ގBdcTjvSGs))M@oݵTlmrLAT32`4-{g.Xqrg/qC/#h QHlʘhMgh[E"S:xD%<7mC`%],\0POq->v6eBrh g8&fG0Hhp ٽp^p0i ĩɑ|{KYg)P(Erh{yvELƮO^k͏ ׉v}GNp8%_SbˊwZ\o^]Z3چQ_xvYY{^!Eʼn=({F_JٯQ2oo ]R4kFO7dN|M->WʘV oOe2b"^VgeQON"=U M~T[VjIتH3[]v.ֽ;^M[3evuwۓWL (t^ѲUk{eQwAZ8xA"'\ڜ]n5նϴg"眩p~e'گ<#d-&܉qּ!^ jS/=9 ֙9ZĪ؃CNFVoUy?Xzcgxƭ0E90&(mA^fn׬^&b,[\|{L[u_+x4}]LXȷM’Go?hMџE%+eKk X!z(|;+6gg;IW*{xo ]{8Ρ4 <4qVkYS]@s]Y/Sŝ Z X&.}MEV}B&v,ŋ0,q8]/boknz4e7^+0Ng%<JDOJ+x],oXۉ3'^*M6G]Dcb-PqIcgdSp-f00\3/}jm+g{0 ıR*k~LP$x &l'EUiaQ҆ $^|҆jQx0U %dÖ҉Yeebot Zo~EikJI0a†5umߟrF>b1hLQR:NHE tPgoI*^ ddϧj,I!O-]̔3c}]g٢/w-恋Q>̶JՒ/5?(mr]I/zǨkK}w3+Xk//u?o ٮ\?e{ّ:䫿efDŽlmnS햁=ʽtJ̭<]srDCJo~jLaG68?q(Cd>yl;'!-Ta4m sK`ڋ?.9^%Gs@WMJ |/jd>m EM-Ic zz}H_P2kyunVn̨7lc碬 W+A1ye(ʄe=]"vpvF:_%M;)^_;[LgG_++Ի©YHLT?EaNş{nj$˜в&BT$7DzY؏e79I>ֿaLz_xA3>q07{WlPϴ5W)8R[]p $b=`ň Xd 2Lr̐؝T[Tsal6#NPlg8Y] DL9htvLYg7~۲=pI ;{/Sc}p_<.|>j6eED4:{է?_=JzYn}vfo&'K,K3C' }fPz >4 e2JLX!Ѿ vn,`kEL ܣ'8X4E[xMTkB+EΚ;oz p%jrF `/jgnowW&;INP4J -j9 hllGj&"i7'C{u܇-g@@W]wf{ ߣε4$wZMlBqԜzU]* 9`.0Ⅺ/G: [=u=)Щj_844f׫xjFCnn:059;g!ĭlO }Оyygl/QZ(LRDw^@. pX;]VͶVFZTE:[2nmt ծiY!ϊVQl28|y^:W.zhT%:ԚКyƱmo|n^(Ts%2 3#~Q(>C R9)4ꐦQuUT]J˅xOfxܝDn%윧zps~n^!B팭sEU xwXx8%:|JM Wu£lM>ip6}*[DWװyJNa+FFcu8\ag0a[B%,^33fYYQT:V'ң[Y9& ֢(e'[pt$ ѳK?cJ|1&6M 4I^#ŗ߼~1ߚX²ފ/+j$ڇw"ɕswUe`2-+ 6AMϣ?٥esm_g_ژ&entsyy|fQ+[Lu/J֟=fV[GW!4;j~wKGWg4fNvU" Aƫ_7;XnMkw񼟶{@ks"W3*_SԿD+(]<= iT?`¶7q ރd jo' p4+)| u_w2y 1s%٘r(÷ﰻn_HvB7>2afz* jo$S6֦Q E1C?KD}qHf|[EU{; R;ua[\o,7 W ?|ƊIB-yEo_\X)2۔;v`¼M[0%+YTA D?dܻˢe\';X(5&q[v3_G*&nbdc,`5;q+E{^8/8F^xڏ,'Ǟyݷ%_JnN'x ] ݔ:5M޶Z2q^c)dӣ 1fH1YVϾ=[.!quh"TRLz'o^6qsne7cJã)W/-u};t@zԷ?$Ϙ_~(Ңb]nX򢔘f:|*f.U"K)~-97n=w,ۭcH72Y},u{d'~z}ThviiBBX.Rn{W)U0ZvfYf97)=GYKҲ(eikC#uZz4cV#y/פ] ~{]@ #GNtORuمVS_m @ ??L+ϋ{P'cF_J=O9--M 𓜃[) ٟ Z]g.LL]e|O|~~㷬JO)di~TxPm{W_Kˊ.o{/8k1laڣɺc@|b==Ko*ԇM*F2=J\]2<+LLغW2+Ln&*aʎzv;nO5oP7َb֖YE!3ٮNɅz;]7Ѥ8+Ny)t­צƬݹym8QnePV؂q_VQA.nCu9یQW9l߈V5=md˴~ 'u{DUa;v jI/3|kIڦ(zdێc,q8]/mkE~jD/E3'vW=[?֤7vEʿO=NZ ޱIKk$V+!ŝ Z X&.}MK?8+i@}_go_x0yÖg;?rQߥ:?箚0+/(<yxȇ^{gi6=K3Ec2ӚX&?M_Wx%}Yڹ3$ 9yx1BE>M+fg%tѮffC}S︰{}_EcuWñڵ)!/1:3>kW9DӳD/X8j=ܨ.&nbtOȫ[ZF}3chsz f֏Vyc;u}RMM( PLM\TXZ:u=)&\<>N}erG+IN=tjϘ3Wњ01s]?gSS媜B'Y q9HFt4ga%/*_NƑ@ck L(e gd9 @|?]bJt&[.0^a>5e$XXƈ!p@ǶsיF+t4-*哙fO 9, 퓠!3^{nL)bwGO,l`{l_G4FXRhn~JHvVSh;I&t &biVR|Ɩ~iS9.5e%mH0iC҃$bUJ?7L&ϧj#<<]qԊ?ݯ?DVj0YL 6Xߒm4?J[(JF}u+Ȩ)c2Kk^|5io[3s 7_/A_d0ę~'-XQmH#D].el3K)lpZKaIL$$E_d46&/'وsY#2=KM:nؠ-~+-~^.IƱ_ï:ӡwmx%5pE6F 7&_zQ^xQ~SV-8O@~ml?U4`¶lZo#2џ!;G|}ya\!{!{I'vm\[%k9y_T,%? T>e&w./&zDF$+:N֣ѓMD3, ,L@Ȉ*SX HlɊx$ ھ 'AR4hA]L2SjKsO?.({ @kE[8}inelBG"IlIY]ԣednm0-e<|uKr **|BMP(ސ~̇[B'b,Ј(BݩK&MED CDw@/p+E!pZDFFWᘌb]k]\M/AdG^'Aj&-_S-rP2 ~/WY]$jf$Gٕ%P$F*Hbp ` ܖ^4ڣG45WvvkH´d;pe\*k&d؇s~E1 KH` /PYn&5:_SguZh_GvxEo/mwh ٶw0a[LTm{Q,6[<_ *K(mٻ-v[W_*hCEx)D]XthΣ[ֈvKPx^?#*%KvQ&C=".KWXl_e idfq zw6W)Hzh3c_EKtVYkn,L F(z}֯3+CN|3+".nC9vgG0%1cbH:Í%ފG㑨 m棧G qDmdVȜ5x켸i}*+F,I ھ76@pv^Zq;y"YVk1Q'u\^_;{F =ݮ"z0,?pb]kЄůp0!^_E#p@F=]l6րtEEWJ0=Ec^6u<2ҳ#D?9WʌlJ{VqYI8)s4{gX+B<*чirFfhj3&LhMaY>o-4,=;[&܎4\g;E>ZCq='_ć*bY{]g6ψ|2͝3ɏBxMĂ{vK7$TL^ ^f=!Mb=@4|rYLQ' }f-tz >4E48ɔcQö{'y]hErԁzcI&oP(;$<ڷ!|P`;7}go{z-^qrE '߶aS6}Dã'Ug;Pfݽ: 2LB$LCDW}|6o5#Gt2wh/4pF\_2\B17v?KMgpox vg='F27{MP <\8 8D 'Xh!f T EVa\gzArZfz1Ɨ(`7hǧ}g4 x/O/Uu)A$Zl/ּ;Hz՝\Nfwj<Fþ(T&?v{uɽ|8睓4rj8z 򔨸$f59;@`)NB6t!lz^GL&;:^]ТWOٻuÄŇPkETsB:wzW_V:vZg.^vfv;=u Ȋ.F:{SJѱ y+2N/DOإ&TUnݢ:o $~/aڿekBwMR;Jog(]2۟iGA@ Z#@)9"gv-P @PS\vU!_[  @h>4a%'vE^>#}|A !r>YV eAuwk_`P.@@ (n]3ݨ P語<9֞v'kQ:_V%zv |{ŁRweBl͈wXx8ZN暆MЉ rˎjuDž#gu΃-tk} ̈́?$o[W@'x^&y;nJ+ Yy.r_ DM I} [.n/ESWеfX`R4-R K_ip"!V194 E^e sI# 9 8zk[2*Ap 7nZlFkkBye+]_,Ew=[%+3ܮ#wN.L2'RQ).]XX.B bo;u2 E$|э8 ۝C)iwGYg;P +_wp2jDÇWN 6%A]{ʑqj $]E)1Wz6G Q\c'SgV-\2Dw.LW(৛97?fhAILat_>24v4zAZ?>VϾ~>|[:r:ߚ 7RMZ{|sAoxS(js7UY~j }YX윃k~ &n<OYZvx`vJ9^*)&ғ7/lr8\aٰ'O/-C*cY"vc'Ûmsjsv~v o,9a90MƖ'Ol.o呫"f̐XW'J3jE>LڔKO:`HA7S.De49Q?=<#ee&Orn /䗖fjv2ǔ.=3 | #e:t Х![M}-3-5i~x]_ESK--+GدF/<[~7dܬD&"wBX6Ӗfgegc*ALa*%dP;.^c@TU?ۀ(#@B\V@%AQI ]t #$On|Ң0-Qv!i%5!Tra L#j0~Ͻw 2?{9Ϲw>swF{E7܄.Tf9b^l'$䖈`J)vGdJ*<ى)!A>)fV|})5ڜv/K(w>rc5qp$ &t_m,ՙ+4+IVVD Vy-=P҃uJzYK:Ne2.?kw|Sl#?6ySO^T=rt0 V!kIyQCUl<9䕛<)uen9n.p{w?+̄.قv%R egccBH )#nU/4vb;x" ᅿbJ' OnvR5TtT$ #ĕlHVOO/f)QUelem9ސG욁;.TEyZXں&P~|ƞL209(}DeQwʊrM7?ݢIE)[\Qfz/QKGZ؏fZ"[1H&I Ҧiȕdt H mX<ؾ0LT; |躑{bvpUM~Lo~^`)_Bpga9H:6:j$oK܏ɾW:߄Z3uX}认ow`ɮ`sNHrޕЫhڭEzE PHa)=uzA3=9{ycNՏ3 )VU(&?w4:s>#JޞXrcndjyf~Qim-1yR{6#3ӆ^|)s/1ঌmsӖގ3$-YϓlX&$WVն)й_6?-,2h6&CnMZ>ӆ MmXHfTbN[i0m&@N&}pG8v\H}^!Kdimyr/wzYf` &}] lC3fJ(i6GY)@\wٓ9ݮxiV/Ǟjcxlsu۷)y<ڊjZJG4̲ydMg4Xp@Ozpv??[? 0|uGR'EyIxsjЏ|gS|_vT΃܏(b,K$dd˘InNQW+ )d^LMMLX!+f׍ ɷ ҂ֺNܶW,J]q7Z.[҂Zv/U,SWm+΍t};~ig8w'^WY&2Cu~ Ag>}ڵYy ;M͇6JWFN^b7.oT?P*wNMqz;#Ա}$^YXD("@˜kNXvB@ 5 BƶK3wު^@~y @@cTѧ!*@qy4xMl g~ @z,VA @ qE @ k #uq%OLv;#tܸf}[~% kg[ j5(   ǕI!pΠm@6$#.ԁiCh\nng@R2F~)e +il!2$4CLVjAn4F+!GZgDtPfI[56[7ժZ1  fɽ_}bw^_7ƒϷ.^bQ3551B3}@}Z!@` 8yR:- =X(f&geƒD"ȝ@H$$k7h_BJN2V7+=wylI'+2qAvf LI3Iֶv* o,8d+7;ƪօc53ݷ#e{lgGOV>f#OK5۴ea Hb~M;$0{9e%̕ϧVtM)TB$ y֟bU&Z$.(c+Zf[X]y<r%%xvJŬcG*lHaJB><7V ,eSUg7Pq_PEYPkTOdI?^c& (I^jَS7DyYT~xQEɤ%?6!, :E&f1O*{Xrdg<t\$*~Ty'YowՇ` *FGWꊾPx\I/qU?~XaL"Ţ喵+Z0jjQ9?aKZZN–/~2/!CP'ĉ5wXkmk~ߪE6|Ogt+.:ptvCg|ۅKs.\3H<+g9?DJ[1ٮR+'<#k!.je/7-3w 𱓧-޼Zfft&Jv 5OPQ r<+KM =J eF g!:@=Z:!ø:VD\ʮoj܆ ƍXHMrs|+_;oUjd8֮a<+i\#Y9D܎|~t|tYzSoJR_v4>_WMƈ>lM&5>, Yj sf8O"]؝~u{p 6v ?ULŚ[D:۾ 'LsJ.xR9^WM kx-Y{Mqvpk ȁx;S8zz=cw ;oȢ4=h>/4=rh3a[a#u}k f|w]E0\P=VxA%/M#D =eh"#S^'r{1.Ƴ2*ɲI2'.4,~c25rN65@ QH!]a˾SRX9YyԆ.h{iE?V$~"$utN\x~;<+1oby::G} '"x*8ZەTJ>X~Ax1lJk=ѲRX-P  Q@8駗rIqB&zGŧĻN%+lWQ~oX/xkm5);8--,%Ss-nr& fbwrN&1%YXa$F+aC)Hc4<R4ph6 scʜyjx %GISkYZ{(O,; GH$-Iz' >FT⻵_(;SfV,vN}J~crq|_+GkD; n8^JWSA7sвyjHc'!a?S|?8 y|ۅKs.\8C@Q0@Ѕ@uIunƭwwATUj,s7}{^yﮌJ2@Tv='lkXΣ&fBec IuۣƺLF?y#M&dPVm͠:F='z=nʓm-Ë7\_ 7d=Vl;F}dptd:(9ۧ#N>N+G 3١Gs ɖ{`o~}7"S¯#==T^OܲbX!&ˋ;3HOSJk(t;b*f|WXs,tzQ0u,}mГM;өyQ[1_F'1 wkQgx>ˌYA-,,:Nڰ&ϐUgB@&24H؟o.HU ϒs 2M|_Kel}}2fٴe1' ?3VtIZON@ _Aa^FȄ` <㩎c3.]nA.=?d*xPY$=G&xaLv;י1˨1NQcLT)B^aAz-B6A ͙sSHO:4CT]Wo{WcۥSYs9*ƭYf܇'{n't|:8u}O4?CD:rgwYz/ϸܯ6PdJ>|s=mf,񚟱庨?}p/1'JϲǎMB̽)l={U"kcZr0WXSLgm[JOI/dz/w4|#R*C'LN4|+vvUc'Nq<!6C ƛ>߼܎^F!\N}^@*%Gk>e⢈[[y3W6vʬQU($e;JuS}ŒkEʹ<\uF)ma8O>AG<2?mG/AI/ ;9^PO/;Q^`ܔs\%x-ƞ?@'泬U=7kovש`dW<@wrN ]?gB `Zǧ^1֖v瓥g}듽&ZWL[Xw:ZVO ?ǵ߾r~7?OE/|fK S|7K$^q^e`:70f2BȨn+msk~d_2ּ̢4y)4rVMn,뻓}MD%o/sK[^zLZɘ{ݓ]'{":9@z>Ytҩ>䙧Ovŋ}xLW=gΜ!.I>av:'C"Qxil0fa5 @r+h  @FP @[Ha @@RXD(@ -܊Z@ Q)F"qo4ֲnkjBv׭Q'{1A8'T^mٕ]߭tɱ4Rj!6MٴڽrW`&-Ayϳ_! UoR\}7eH ſLǥU0Bq.`ly!NTvỞ阁绅%s7?90ֻwM] =#.T#k*IK̰Zjl ZDО#`,o@PWP`j"`o=m-%LI7㇓V{;M7/̜J+mZ3#ϻV]k֕eᔪ:}wN?>iLz%ɘe/BP%xZThm" 0[9|yn!2y'c'Nq@[9cB'k2 wݺy֪R1;|y'MUgN|_=.%&ZdF=S򖏶7<=d@|a~~s_~h^$Ahk&ږߐ;|뎊C)0h]u |ߢV<*cS+[MYc 6dWJ0#r`;Z0[XqH3|5Ƅo`0na'/3Ѹљhݭ; Ī?Gߝ)LI4ѽv Haehne9侁?nb z8{s!g(gƼzxڳz.sVkl]0iZA]&TțB~g/̝\oUTZg.펣k]~9>MurZߑgU&A{&{uL'}緺w(@7c7/v~֗y;{h t!g;R_ʷ{yø .y=X7YvCƒ ݝ;pLwҽ4}NK^xm͙3g 91'Kߧ}N*Eއ_~|Z.*sOh}h}pŝKc1  5} RP1 clN`i@?g# N0T~BG)l8( @:@ 3JT@ ?HaG @ЙRXQ(@u& +_M(_=ݏ8;Rwg@z#VoBȕWF&?ʥMt#[,e~Nweu R)2^Z`> @2ԋ&Z7 &Q5rk}g@}$`Q ȚJSv>P1Lչ1^T;p0/sԟ$m9!2?]SZt )3b>Fǯ-)"=R~ap4z%W|y>onZioJNAFx up"?6 =ٶ|QE;xmmf֓`~x5tdX(+[*-k]]ǹR2A+?oWS{Qk73^)WL/4kFWIF}NPAI-Dvu^k;xa4'³UglyDyu}S!5q VVC?!@RX h!$9ﱳ =8c˪Dc^fec*g[qoz̘eԊ¯ TSZ5,* aj2m|bg2p< #,wkR IWR~u9){.̘ԲB5QZLz\˨̼uf |)lLrﺗͿCg @Dph48;, L43 $;5|0s~P` s9׽u--7J}i <錀U}W]0{d>ś0kK?`.{-zo⮖ mVFiKLLE;Ώ?dP+Y*$Fz5rW,c@7W<+CLfg} ?ne܈|<髪d]]:^PZ)c4ZCoeMU]f{cYjjſCp$m:b<3xT3W #UM7 WK&GY_Fӓibz{zo(<\\A7H[}ѹl&Rdִ֝LmnvmDsM:MD S4QMt`KTwr=SZ/p4O.QӼK @'RXgm yj/Ox~%jڷge; @ p"s6%$b3e?{)7gQGw @JH^BgjfF-3xPӢ @}#ozZ!@P)] @-VA =@ AE @~ w @@aP%@ Ha; @CzTt  RX/z@P)] @-VA =@ AE @~ w @@aP%@ Ha; @CzTt  RX/z@P)] @-VA =@ AE @~ w @@aP%@ Ha; @CzTt  RX/z@P)] @-VA =@ AE @~ w @@aP%@ Ha; @CzTt  RX/z@P)] @-VA =@ AE @~ w @@aP%@ Ha; @CzTt  RX/z@P)] @-VA =@ AE @~ w @@aP%@ Ha; @Cg>}B @W@y [[[]3ss!.HK U }B!(04}pŝKc@# @ pK),@ h@  @)IDAT%[@k @4 H @@ ˭x5 @j$B@ n V<@8#7D73-ƕ4>)l\7B9F'kЌݯ݃NʓG (W}rtvF\%jhk^%qlSBvdPVm͠:F=.'z=nʓm-Ë s{234.R*`۱OǕI!>S2iw8O{:qw>g-vQǗĹ7I'SK/Zk !홾KDVy k܅Vʨ}BW$SٞUr/)Eg_۾iY=5{ڕPJZ5W\KRm@\*"&k[Ou"Lrپb96i;&[h ƒϷ.^b~i+ԣgdۺ8gPz}{z#ƥC^SGe;3~Ofɽ˿x<żBphmU&T$A0Ł[j}cۿA'o#7LZL_"<gD3m_V8'P)>:];~VGSvFh f^a|VT.S_asҶ vB7/[rj 0?@B :Oqi_[?Sk1s 6Dn?eB(bʦ=7#Nɱw ><eQU $Mz' >g/lygŠEn>8Yɳߘ)VZ~m9_o>J~%.9*n5vX?y<، u͕߳$7Bfy?xkNQ )??:L=U]#*ixtfN! {NjՎb+u(iLZ^ilWc]U$R1sK쌧ΗD["O[VYW}7dV]}C+{r0>ٟ+ \\U^.pk<}{YC>û^=pkgOqNN}:*Lϙ<ד {qx/̍LDY[ i|(hە-]BْT|)p{R[>e$ty =&WN_GV_ۓ.iU|;pt3En!E Ix-=PݙF~KmK[>E9EewT-XgccB):#nUM;ي̡LcKr.Bfj%Auɔs *{<ًD S>A;(ηu[^}LUQ9B #4_?o">'t3:5ޞ2eQ#N !cOS}탓̨?a9=#V(C)]O:j$j(C\Wdxx:[V6ݹ8H|sxۯЙ -OCCxHa! 0WKfZ˹{W?'Ƙ k{jY9D܎|~4Ս r_MJ>] /okXΣ&mVjly#UFﺩƊ}ƺLFj{ⱗ=%uGdO;cIu[k{ o\iͣ B߷>:5e\N^!푣]~;ֹ}ޑUɮXNj I7D)VW+&9X}_7o_q& ݩP\:f<Ƈ:t`Z78xGgڨo8#!dX:6Sx+-yMOkwJ4خHV6:5zۖAB죱],SuwK^12~7-ŇR>LP>QhZ.8p8(@ոkaCmka-kz-Y,_E@oQl|Y'Z@ n>%$`H @T SZR%Ȟ1&4 @;Jae~u+pgCN@ V3ɢV־9.k<˙6a@ pQ#LSF|Ѧ-~|4B @83 +L0"ֹCT 0KƕngΝW'1t%"nԔWy1,K>ߺt{ E5T3+~b#޻>%"T{պvۻb~V 2im\q 1$5~Tƾ3I]}V>L|s%Nvr83ȥLy{O~o!^P.v(P??+wr?gE=CY ;gz;iI\od$S44i/IE%'?՞;r#|G6Dz 3mm`nnNJ*3vgom:yfJ jf?Q.% TJ0aiyF4;ettf\I aOv̑ws"Q6cb0uPE@4w]H8w"{6\>VŒΓdAfEƱ}tK*gܵ6 F7P=-2ieb"<0tu($ﮌN,֥I9ۆ"䤩셥GY]ʴ\h7%c襋8P _Ťl4;FE24Ф28̻q!]m]K %߽Rp fb]?x[Y/֞*?*2u;jWꢝ6I >GT2c3>/lǩ|G,*?ĢdNgwZq, :E&f1Oyޅy@siI;Tk>~YdƶR!]go#+huE 1k|(⚚m-j,93 :_.oq*Ǣ5 ~煟:Xw9:,Կ=`ģƺLF?x#M&SMgܸkҫJQ(+XQdqч[;{z_"TwǼԔ,zI*RRKy؏S/\ҏ|=E,y2RP 4ebi5O`?߯4=1wSk%nh ^|Լhپ09i{'_& Tp.SZmC)=_=D?nBeKZPU-(/rѫEۍ+M8HIZ'UF{+ӧOV7/nC\`F{ 8wGczftw}pKcw`=A@ !"v݄ @#Vb@ !"v݄ @#Vb@ !"v݄ @#Vb@'{Kk L t؞QW`g@ @@ ǕI!pǟwog[hKB3n3`eZ "tE41+ԡ+\vo?`CB IRtN@^řw_;&6CwLMMА{m-z\U]7ߞ6EƼ:X/ܦ'VW'ƚM?l99%ț33' 9`h3 %\2(GRL&=fFFo$smˈ!`NT'St̯ƕߝC"1}[72.:۰r!_t pNR̾OEٺ;һN<7F1eH>ƶ)HcR$SfA)|p;V-5<;β\j/6Q̯r0 T)lOxn,=1Go9H-JKDT:PYwh55 I[jDE,[ŏ&LYXmG'+e|A|1֞4q$^kET# @CVuɔԳ%-Y'k\z{K!.P? ZB? m?;,jyNƕwJn7 3qqG!(04}p WZ@ p;K+& @RX- @J)VL(@ ܉Z@ RXP @;Ha  @@+Z1 @wr'h  @VHabB!@  N,@ jńB @@ ˝X% @Z Պ @#;@K @@  A pG),wb@ h%V+& @RX- @J)VL(@ ܉Z@ RXP @;Ha  @@+Z1 @wr'h  @VHabB!@  N,@ jńB @@ ˝X% @Z Պ @#;@K @@  A pG),wb@ h%V+& @RX- @J)VL(@ ܉Z@ RXP @;<};AK @ QP @[Ha @@RXD(@ -܊Z@ Q)F" @RXn @(V# @ pK),@ h@  @%[@k @4 H @@ ˭x5 @j$B@ n V<@ Ha5 @r+h  @FP @[Ha @@RXD(@ -܊Z@ Q)F" @RXn @(V# @ pK),@ h@  @%"uL,IENDB`$$If!vh#v #v#vX#v|#v:V l0x!5 55X5|54ytmq$$If!vh#v #vl:V l40x!5 5l4f4ytmq$$If!vh#v #v#vX#v|#vT#v:V l0x!5 55X5|5T54ytmq$$If!vh#v #v#vX#v|#vT#v:V l0x!5 55X5|5T54ytmq$$If!vh#v #v#vX#v|#vT#v:V l0x!5 55X5|5T54ytmq$$If!vh#v #vl:V l0x!5 5l4ytmq$$If!vh#v #vl:V l40x!5 5l4f4ytmq$$If!vh#v #vl:V l40x!5 5l4f4ytmqDd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >  # "@@Dd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >  # "@@Dd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >   # "@@Dd >   # "@@ Dd `   3 .bulletBlueDot"@@ Dd >   # "@@ Dd >   # "@@ Dd `  3 .bulletBlueDot"@@ Dd >  # "@@Dd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >  # "@@Dd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >  # "@@Dd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >  # "@@Dd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >  # "@@Dd >  # "@@Dd `  3 .bulletBlueDot"@@Dd >  # "@@Dd >  # "@@Dd `   3 .bulletBlueDot"@@Dd > ! # "@@ Dd > " # "@@!Dd ` # 3 .bulletBlueDot"@@"Dd > $ # "@@#!s666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH DA`D Default Paragraph FontRi@R  Table Normal4 l4a (k (No List 4@4 pSHeader  !@ @@ pS0Footer  ! mHsHtH<^< 3A Normal (Web) d\$*W !* 3AStrong5\hP2h 940 Body Text 2p^p`"5CJOJQJ\aJmHsHtHR/AR 940Body Text 2 Char5CJOJQJ\^JaJjRRj 940Body Text Indent 2 ^"6CJOJQJ]aJmHsHtH`/a` 940Body Text Indent 2 Char6CJOJQJ]^JaJ6U`q6 0 Hyperlink >*B*phvv [ Medium Grid 1 - Accent 2d^m$CJOJPJQJaJ6/6 {0 Footer CharCJaJNoN +jBody)B*CJOJPJQJ_HmH phsH tH PP Q0 Balloon TextCJOJQJaJmHsHtHN/N Q0Balloon Text CharCJOJQJ^JaJjj + Table Grid7:V0FV F % 0FollowedHyperlink >*B*ph`@` [ Colorful List - Accent 1 ^m$CJaJbb Q List Paragraph d^m$CJOJPJQJaJPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VvnB`2ǃ,!"E3p#9GQd; H xuv 0F[,F᚜K sO'3w #vfSVbsؠyX p5veuw 1z@ l,i!b I jZ2|9L$Z15xl.(zm${d:\@'23œln$^-@^i?D&|#td!6lġB"&63yy@t!HjpU*yeXry3~{s:FXI O5Y[Y!}S˪.7bd|n]671. tn/w/+[t6}PsںsL. J;̊iN $AI)t2 Lmx:(}\-i*xQCJuWl'QyI@ھ m2DBAR4 w¢naQ`ԲɁ W=0#xBdT/.3-F>bYL%׭˓KK 6HhfPQ=h)GBms]_Ԡ'CZѨys v@c])h7Jهic?FS.NP$ e&\Ӏ+I "'%QÕ@c![paAV.9Hd<ӮHVX*%A{Yr Aբ pxSL9":3U5U NC(p%u@;[d`4)]t#9M4W=P5*f̰lk<_X-C wT%Ժ}B% Y,] A̠&oʰŨ; \lc`|,bUvPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!R%theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] W //MMMP4 4z "?%d*2 4489<BGK)OyRUWVNXKY`^m^z^__023567CDFHJLMO^`acdeghjuvwy$%@AHI`b$)a-499:I:s::::;>;m;;;;;?@ABEGIKNPQRSTUVWXYZ[\]_bfiklmnopqrstx90d0z0)G|GGK@LzL6MtMMWXXXX/GIP!@ @H 0(  0(  B S  ?_PictureBullets^VWVWct 6G%%,,'040V:]:>>BEFEHHRRCTGT^VVVVVVVVVVVWWY`f#k#6'?' >>^VVVVVVVVVVVWW33334Q+++, , , ,,--////'04070}0003111488=VVWWW/ @x}^"{Pfn4^KeuXd# !C h.V/V/?v *rt] ;bzyx$CʫPH>Eh> `&HC-*ڒ"2Ye,L4&9{-L4&Xu?.SC. zCJv0&X^<Ҹs=e<(;6C0tNLX|Q!tV(acZ>|^Ćl)cTrNyg[-gYVi`e҈OKl`Cvm],tYo`OAp  pBph:Yt],btVzj5Qv"X}jv63_)z66;mZ{bNB¢2 ^`OJQJo( 8^8`OJQJo(^`OJQJ^Jo(o  p^ `OJ QJ o(  @ ^ `OJ QJ o( x^x`OJQJo(H^H`OJQJ^Jo(o ^`OJ QJ o( ^`OJ QJ o(h ^`hH.h p^p`hH.h @ L^@ `LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h P^P`hH.h  L^ `LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJ QJ o(hH  ^`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. h 8^8`o(hH.h ^`hH.h  L^ `LhH.h  ^ `hH.h x^x`hH.h HL^H`LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h ^`hH.h p^p`hH.h @ L^@ `LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h P^P`hH.h  L^ `LhH. ^`o(hH. 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH.h ^`hH. ^`o(hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^h`o(h^h`o(.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJ QJ o(hHh^h`o(h^h`OJPJQJ^J.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJ QJ o(hHh^h`o(h^h`OJPJQJ^J.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........h 8^8`hH.h ^`hH.h  L^ `LhH.h  ^ `hH.h x^x`hH.h HL^H`LhH.h ^`hH.h ^`hH.h L^`LhH.hh^h`B*OJQJo(phhH^`OJQJ^Jo(hHo^`OJ QJ o(hHpp^p`OJQJo(hH@ @ ^@ `OJQJ^Jo(hHo^`OJ QJ o(hH^`OJQJo(hH^`OJQJ^Jo(hHo^`OJ QJ o(hHh^h`o(h h^h`hH.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........h^h`o(h h^h`hH.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^`OJQJo(hHh^`OJQJo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJo(hHohP^P`OJ QJ o(hHh^h`o(h^h`o(.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJ QJ o(hHh^h`>*o(h^h`>*OJPJQJ^J.0^`0>*o(..0^`0>*o(... 8^8`>*o( .... 8^8`>*o( ..... `^``>*o( ...... `^``>*o(....... ^`>*o(........ ^`hH. ^`hH. e L^e `LhH. 5 ^5 `hH. ^`hH. L^`LhH. ^`hH. u^u`hH. EL^E`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH.h p^p`hH.h @ L^@ `LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h P^P`hH.h  L^ `LhH.^`^J.^`^J.pL^p`L^J.@ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PL^P`L^J.h ^`hH.h p^p`hH.h @ L^@ `LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h P^P`hH.h  L^ `LhH. ^`hH.^`o(. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH. ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^h`o(h^h`OJPJQJ^J.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h 8^8`o(hH.h 8^8`hH.0^`0o(..0^`0o(... ^`o( .... ^`o( ..... p`^p``o( ...... p`^p``o(.......  ^ `o(........h^h`o(. 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH.h ^`hH.h p^p`hH.h @ L^@ `LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h P^P`hH.h  L^ `LhH.h ^`hH.h p^p`hH.h @ L^@ `LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h P^P`hH.h  L^ `LhH.h h^h`o(hH.h h^h`hH.0^`0o(..0^`0o(... 8^8`o( .... 8^8`o( ..... `^``o( ...... `^``o(....... ^`o(........ ^`hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH. ^`o(hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH. ^`o(hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. U^U`hH. %^%`hH.  L^ `LhH.  ^ `hH. ^`hH. eL^e`LhH. 5^5`hH. ^`hH. L^`LhH. 8^8`o(hH. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH.h p^p`hH.h @ L^@ `LhH.h ^`hH.h ^`hH.h L^`LhH.h ^`hH.h P^P`hH.h  L^ `LhH./C-*VHs=e< ViJv0zyxl)cx} pBpN] |QeunOAp!C # PC(acZ^<}jvtNL`&mZ{V//?;Qv;tYo9{-AYe,vmh:YtXu?.-g  (;6C _)z bt|^OKlhNygC.PcQ tpTeUro<pPwg6':h:,3,3,3:Pwg6':hӤ:,3,3,3://                  @                 ִ                          Vv         0(                pXz                                  v4                                    ӊ                                             @t                                                                        vD7        *D       (        `V                 ) _4!A dj@ 4!A $ ^l :O y4!A )4!A 33"@|"+#4!A ds*yz%*!}+3,-4!A 24!A d)G7 9wb:v:4!A d0;4!A C1=nVxA4!AUf fw!&HS774Z4!A Z]N/, B \Qmqj#j5648n^8T<=@?GAc2CiFHaH=JNWN~7O&WZ[ b+acq9r{rv{#|N~b=q;eR}/t$(J[-I6":W/?m6\v;ru]dbK+cVV@BEBEBEBEW@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.@Calibri3*Ax Times;. *Cx HelveticaC0000҉0 Pro W35. .[`)Tahoma?= *Cx Courier New;WingdingsA$BCambria Math"1hmEgJHGj I , I ,!4WVWVQ 2qHP ?^V 2! xx , Pharmacy NameCOPWilliams,Trinity H/                           ! " # $ % & ' ( ) * + , - . Oh+'0|   , 8 D P\dltPharmacy NameCOPNormalWilliams,Trinity H4Microsoft Office Word@Ik@$6嘕@,@<F  I՜.+,D՜.+,8 hp|  UA,WV Pharmacy Name Title 8@ _PID_HLINKSAh!t /http://www.counseling.ufl.edu/cwc/Default.aspx:http://pharmacy.ufl.edu/experiential/contact-information/QCAhttp://www.dso.ufl.edu/sccr/process/student-conduct-honor-code/)Phttp://www.pharmacademic.com/  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz|}~      !"#$%&'(*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{}~Root Entry F];FData {Z1Table)nWordDocument4SummaryInformation(|DocumentSummaryInformation8CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q